.. .. Généralités,

.. .. Embryologie,

.. .. Anatomie,

.. .. Histologie,

.. .. Fonctions,

B. , L. Cancer-de-la-prostate, and .. .. ,

.. .. Incidence,

.. .. Mortalité,

.. .. Origines-ethno-géographiques,

.. .. Antécédents-familiaux-de-cancers,

.. .. Antécédents, 3.2 Antécédents familiaux de cancer autre que la prostate

.. .. Facteurs,

. .. Gènes-de-prédisposition,

.. .. Polymorphismes-de-susceptibilité-génétique,

.. .. Facteurs,

.. .. Obésité,

.. .. Facteurs,

.. .. Environnement-chimique,

.. .. Pesticides,

, Méta-analyses

.. .. Études-cas-témoins, Études oupl es à des esu es iologi ues d'expositio, vol.87

.. .. Aut-es-su-sta-es-hi-i-ues-d'expositio,

.. .. Perturbateurs,

M. C. References-alavanja, C. Samanic, M. Dosemeci, J. Lubin, R. Tarone et al., Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort, Am J Epidemiol, vol.157, pp.800-814, 2003.

K. J. Aronson, J. W. Wilson, M. Hamel, W. Diarsvitri, W. Fan et al., Plasma organochlorine levels and prostate cancer risk, J Expo Sci Environ Epidemiol, vol.20, pp.434-445, 2010.

Å. Bergman, A. M. Andersson, G. Becher, M. Van-den-berg, B. Blumberg et al., Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors, Environ Health, vol.12, p.69, 2013.

J. T. Bernert, W. E. Turner, D. G. Patterson, and L. L. Needham, Calculation of serum "total lipid" concentrations for the adjustment of persistent organohalogen toxicant measurements in human samples, Chemosphere, vol.68, pp.824-831, 2007.

G. Carruba, Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario, Cell Biochem, vol.102, pp.899-911, 2007.

C. H. Christensen, E. A. Platz, G. Andreotti, A. Blair, J. A. Hoppin et al., Coumaphos exposure and incident cancer among male participants in the Agricultural Health Study (AHS), 2010.

, Environ Health Perspect, vol.118, pp.92-96

M. M. Center, A. Jemal, J. Lortet-tieulent, E. Ward, J. Ferlay et al., International variation in prostate cancer incidence and mortality rates, Eur Urol, vol.61, pp.1079-1092, 2012.

, Centers for Disease Control and Prevention, p.11, 2009.

T. Colborn, F. S. Vom-saal, and A. M. Soto, Developmental effects of endocrine-disrupting chemicals in wildlife and humans, Environ Health Perspect, vol.101, pp.378-384, 1993.

P. S. Cooke, T. Sato, and D. L. Buchanan, Disruption of steroid hormone signaling by PCBs, recent Advances in Environmental Toxicology and Health effects, pp.257-263, 2001.

J. E. Damber and G. Aus, Prostate cancer. Lancet, vol.371, pp.1710-1721, 2008.

C. Debier, P. P. Pomeroy, C. Dupont, C. Joiris, V. Comblin et al., Quantitative dynamics of PCB transfer from mother to pup during lactation in UK grey seals Halichoerus grypus, Mar Ecol Prog Ser, vol.247, pp.237-248, 2003.

E. Diamanti-kandarakis, J. P. Bourguignon, L. C. Giudice, R. Hauser, G. S. Prins et al., Endocrine-disrupting chemicals: an Endocrine Society scientific statement, Endocr Rev, vol.30, pp.293-342, 2009.

S. M. Dickerson, S. L. Cunningham, H. B. Patisaul, M. J. Woller, and A. C. Gore, Endocrine disruption of brain sexual differentiation by developmental PCB exposure, Endocrinology, vol.152, pp.581-594, 2011.

D. R. Dietrich, A. Sv, H. Marquardt, B. Blaauboer, W. Dekant et al., Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles, Chem Biol Interact, vol.205, pp.1-5, 2013.

S. J. Ellem and G. P. Risbridger, The dual, opposing roles of estrogen in the prostate, Ann N Y Acad Sci, vol.1155, pp.174-186, 2009.

S. J. Ellem and G. P. Risbridger, Aromatase and regulating the estrogen:androgen ratio in the prostate gland, J Steroid Biochem Mol Biol, vol.118, pp.246-251, 2010.

E. Emeville, F. Giton, A. Giusti, A. Oliva, J. Fiet et al., Persistent organochlorine pollutants with endocrine activity and blood steroid hormone levels in middle-aged men, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00876025

, PLoS One, vol.8, p.66460

D. Fagin, The learning curve, Nature, vol.490, pp.462-465, 2012.

A. C. Gore, J. Balthazart, D. Bikle, D. O. Carpenter, D. Crews et al., Policy decisions on endocrine disruptors should be based on science across disciplines: a response to, Dietrich et al. Endocrinology, vol.154, pp.3957-3960, 2013.

S. Gupta, K. Hastak, N. Ahmad, J. S. Lewin, and H. Mukhtar, Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols, Proc Natl Acad Sci U S A, vol.98, pp.171-89, 1998.

A. W. Hsing and A. P. Chokkalingam, Prostate cancer epidemiology. Front Biosci, vol.11, pp.1388-1413, 2006.

, Working group on the evaluation of the carcinogenic risk of chemicals to humans. Occupational exposures in insecticide application, and some pesticides. IARC monographs on the evaluation of carcinogenic risks to humans, vol.53, pp.179-250, 1991.

W. R. Kelce, C. R. Stone, S. C. Laws, L. E. Gray, J. A. Kemppainen et al., Persistent DDT metabolite pp'-DDE is a potent androgen antagonist, Nature, vol.376, pp.581-585, 1995.

W. R. Kelce, C. R. Lambright, L. E. Gray, and K. P. Roberts, Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptormediated mechanism, Toxicol Appl Pharmacol, vol.142, pp.192-200, 1997.

S. Koutros, L. E. Beane-freeman, J. H. Lubin, S. L. Heltshe, G. Andreotti et al., Risk of total and aggressive prostate cancer and pesticide use in the Agricultural Health Study, 2013.

, Am J Epidemiol, vol.177, pp.59-74

P. A. Kupelian, C. A. Reddy, A. M. Reuther, A. Mahadevan, J. P. Ciezki et al., Aggressiveness of Familial Prostate Cancer, J Clin Oncol, vol.24, pp.3445-3450, 2006.

J. Li, N. Li, M. Ma, J. P. Giesy, and Z. Wang, In vitro profiling of the endocrine disrupting potency of organochlorine pesticides, Toxicol Lett, vol.183, pp.65-71, 2008.

R. Little and D. B. Rubin, Statistical Analysis with Missing Data, 1987.

S. M. Lynch, R. Mahajan, L. E. Beane-freeman, J. A. Hoppin, and M. C. Alavanja, Cancer incidence among pesticide applicators exposed to butylate in the Agricultural Health Study (AHS), 2009.

, Environ Res, vol.109, pp.860-868

R. Mahajan, M. R. Bonner, J. A. Hoppin, and M. C. Alavanja, Phorate exposure and incidence of cancer in the Agricultural Health Study, Environ Health Perspect, vol.114, pp.1205-1209, 2006.

V. A. Mcfarland and J. U. Clarke, Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis, 1989.

A. Melchini, M. H. Traka, S. Catania, N. Miceli, M. F. Taviano et al., Antiproliferative activity of the dietary isothiocyanateerucin, a bioactive compound from cruciferous vegetables, on human prostate cancer cells, Environ Health Perspect, vol.81, pp.132-138, 2013.

T. O. Morgan, S. J. Jacobsen, W. F. Mccarthy, D. J. Jacobson, D. G. Mcleod et al., Agespecific reference ranges for prostate-specific antigen in black men, N Engl J Med, vol.335, pp.304-310, 1996.

L. Multigner, J. R. Ndong, A. Giusti, M. Romana, H. Delacroix-maillard et al., Chlordecone exposure and risk of prostate cancer, J Clin Oncol, vol.28, pp.3457-3462, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00518099

S. M. Oh, B. T. Ryu, S. K. Lee, and K. H. Chung, Antiestrogenic potentials of ortho-PCB congeners by single or complex exposure, Arch Pharm Res, vol.30, pp.199-209, 2007.

W. Owens, L. E. Gray, E. Zeiger, M. Walker, K. Yamasaki et al., The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies, Environ Health Perspect, vol.115, pp.671-678, 2007.

M. Pavuk, J. R. Cerhan, C. F. Lynch, A. Schecter, J. Petrik et al., Environmental exposure to PCBs and cancer incidence in eastern Slovakia, Chemosphere, vol.54, pp.1509-1520, 2004.

M. Plísková, J. Vondrácek, R. F. Canton, J. Nera, A. Kocan et al., Impact of polychlorinated biphenyls contamination on estrogenic activity in human male serum, 2005.

, Environ Health Perspect, vol.113, pp.1277-1284

M. Porta, M. Jariod, T. López, J. Pumarega, E. Puigdomènech et al., Correcting serum concentrations of organochlorine compounds by lipids: alternatives to the organochlorine/total lipids ratio, Environ Int, vol.35, pp.1080-1085, 2009.

G. S. Prins, Endocrine disruptors and prostate cancer risk, Endocr Relat Cancer, vol.15, pp.649-656, 2008.

S. Radice, E. Chiesara, S. Fucile, and L. Marabini, Different effects of PCB101, PCB118, PCB138 and PCB153 alone or mixed in MCF-7 breast cancer cells, Food ChemToxicol, vol.46, pp.2561-2567, 2008.

J. M. Ritchie, S. L. Vial, L. J. Fuortes, H. Guo, V. E. Reedy et al., Organochlorines and risk of prostate cancer, J Occup Environ Med, vol.45, pp.692-702, 2003.

J. M. Ritchie, S. L. Vial, L. J. Fuortes, L. W. Robertson, H. Guo et al., Comparison of proposed frameworks for grouping polychlorinated biphenyl congener data applied to a case-control pilot study of prostate cancer, Environ Res, vol.98, pp.104-113, 2005.

D. B. Rubin, Multiple Imputation for Nonresponse in Surveys, 1987.

S. Safe, Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: progress and problems, Environ Health Perspect, vol.100, pp.259-268, 1993.

N. Sawada, M. Iwasaki, M. Inoue, H. Itoh, S. Sasazuki et al., Plasma organochlorines and subsequent risk of prostate cancer in Japanese men: a nested casecontrol study, Environ Health Perspect, vol.118, pp.659-665, 2010.

S. R. Seaman, J. W. Bartlett, and J. R. White, Multiple imputation of missing covariates with nonlinear effects and interactions: an evaluation of statistical methods, BMC Med Res Methodol, vol.12, p.46, 2012.

I. A. Siddiqui, V. M. Adhami, F. Afaq, N. Ahmad, and H. Mukhtar, Modulation of phosphatidylinositol-3-kinase/protein kinase B-and mitogen-activated protein kinasepathways by tea polyphenols in human prostate cancer cells, J Cell Biochem, vol.91, p.232, 2004.

A. M. Soto and C. Sonnenschein, Environmental causes of cancer: endocrine disruptors as carcinogens, Nat Rev Endocrinol, vol.6, pp.363-370, 2010.

C. A. Thompson, Z. F. Zhang, and O. A. Arah, Competing risk bias to explain the inverse relationship between smoking and malignant melanoma, Eur J Epidemiol, vol.28, pp.557-567, 2013.

, Report on Carcinogens, Thirteenth Edition, National Toxicology Program, p.11, 2014.

S. Van-buuren, H. C. Boshuizen, and D. L. Knook, Multiple imputation of missing blood pressure covariates in survival analysis, Statist Med, vol.18, pp.681-694, 1999.

M. A. Verner, D. Bachelet, R. Mcdougall, M. Charbonneau, P. Guénel et al., A case study addressing the reliability of polychlorinated biphenyl levels measured at the time of breast cancer diagnosis in representing early-life exposure, Cancer Epidemiol Biomarkers Prev, vol.20, pp.281-286, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00720834

N. S. Weiss, Adjusting for screening history in epidemiologic studies of cancer: Why, when, and how to do it, Am J Epidemiol, vol.157, pp.957-961, 2003.

I. R. White, P. Royston, and A. M. Wood, Multiple imputation using chained equations: Issues and guidance for practice, Statist Med, vol.30, pp.377-399, 2009.

A. Bergman, J. J. Heindel, S. Jobling, K. A. Kidd, and R. T. Zoeller, State of the science of endocrine disrupting chemicals 2012, p.11, 2013.

X. Xu, A. B. Dailey, E. O. Talbott, V. A. Ilacqua, G. Kearney et al., Associations of serum concentrations of organochlorine pesticides with breast cancer and prostate cancer in U.S. adults, Environ Health Perspect, vol.118, pp.60-66, 2010.

M. M. Center, A. Jemal, J. Lortet-tieulent, E. Ward, and J. Ferlay, International variation in prostate cancer incidence and mortality rates, Eur Urol, vol.61, pp.1079-1092, 2012.

A. W. Hsing and A. P. Chokkalingam, Prostate cancer epidemiology. Front Biosci, vol.11, pp.1388-1413, 2006.

J. E. Damber and G. Aus, Prostate cancer. Lancet, vol.371, pp.1710-1721, 2008.

C. Chen, Risk of prostate cancer in relation to polymorphisms of metabolic genes, Epidemiol Rev, vol.23, pp.30-35, 2001.

J. D. Hayes, J. U. Flanagan, and I. R. Jowsey, Glutathione transferases, Annu Rev Pharmacol Toxicol, vol.45, pp.51-88, 2005.

T. R. Rebbeck, Molecular epidemiology of the human glutathione Stransferase genotypes GSTM1 and GSTT1 in cancer susceptibility, Cancer Epidemiol Biomarkers Prev, vol.6, pp.733-743, 1997.

T. J. Monks, M. W. Anders, W. Dekant, J. L. Stevens, and S. S. Lau, Glutathione conjugate mediated toxicities, Toxicol Appl. Pharmacol, vol.106, pp.1-19, 1990.

F. P. Guengerich, Activation of dihaloalkanes by thiol-dependent mechanisms, J Biochem Mol Biol, vol.36, pp.20-27, 2003.

C. Ntais, A. Polycarpou, and J. P. Ioannidis, Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis, Cancer Epidemiol Biomarkers Prev, vol.14, pp.176-181, 2005.

Z. Mo, Y. Gao, Y. Cao, F. Gao, and L. Jian, An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review, Prostate, vol.69, pp.662-688, 2009.

M. Gong, W. Dong, Z. Shi, Y. Xu, and W. Ni, Genetic Polymorphisms of GSTM1, GSTT1, and GSTP1 with Prostate Cancer Risk: A Meta-Analysis of 57 studies, Plos One, 2012.

B. Wei, Z. Xu, Y. Zhou, J. Ruan, and H. Cheng, Association of GSTM1 Null Allele with Prostate Cancer Risk: Evidence from 36 Case-Control Studies, Plos One, 2012.

Q. Yang, J. Du, and X. Yao, Significant Association of Glutathione STransferase T1 Null Genotype with Prostate Cancer Risk: A Meta-Analysis of 26,393 Subjects, Plos One, 2013.

E. Taioli, R. E. Flores-obando, I. Agalliu, P. Blanchet, and C. H. Bunker, Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent, Carcinogenesis, vol.32, pp.1361-1365, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00682901

C. Minelli, R. Granell, R. Newson, M. J. Rose-zerilli, and M. Torrent, Glutathione-S-transferase genes and asthma phenotypes. A Human Genome Epidemiology (HuGE) systematic review and meta-analysis including unpublished data, Int. J. Epidemiol, vol.39, pp.539-562, 2010.

R. A. Mclellan, M. Oscarson, A. K. Alexandrie, J. Seidegård, and D. A. Evans, Characterization of a human glutathione S-transferase mu cluster containing a duplicate GSTM1 gene that causes ultrarapid enzyme activity, Mol Pharmacol, vol.52, pp.958-965, 1997.

C. Bruhn, J. Brockmoller, R. Kerb, I. Roots, and H. H. Borchert, Concordance between enzyme activity and genotype of glutathione S-transferase beta (GSTT1), Biochem. Pharmacol, vol.56, pp.1189-1193, 1998.

S. Xu, Y. Wang, B. Roe, and W. R. Pearson, Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion, J Biol Chem, vol.273, pp.3517-3527, 1998.

R. Sprenger, R. Schlagenhaufer, R. Kerb, C. Bruhn, and J. Brockmöller, Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation, Pharmacogenetics, vol.10, pp.557-565, 2000.

, GSTM1 and GSTT1 Copy Number Variation and Prostate Cancer Risk

E. Emeville, F. Giton, A. Giusti, A. Oliva, J. Fiet et al.,

, PLoS ONE, vol.8, issue.6, p.66460

E. Diamanti-kandarakis, J. P. Bourguignon, L. C. Giudice, R. Hauser, and G. S. Prins, Endocrine-disrupting chemicals: an Endocrine Society scientific statement, Endocr Rev, vol.1, pp.293-342, 2009.

R. T. Zoeller, T. R. Brown, L. L. Doan, A. C. Gore, and N. E. Skakkebaek, Endocrine-disrupting chemicals and public health protection: a statement of principles from the endocrine society, Endocrinology, vol.153, pp.4097-4110, 2012.

E. Diamanti-kandarakis, E. Palioura, S. A. Kandarakis, and M. Koutsilieris, The impact of endocrine disruptors on endocrine targets, Horm Metab Res, vol.42, pp.543-552, 2010.

A. M. Soto and C. Sonnenschein, Environmental causes of cancer: endocrine disruptors as carcinogens, Nat Rev Endocrinol, vol.6, pp.363-370, 2010.

B. J. Danzo, Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins, Environ Health Perspect, vol.105, pp.294-301, 1997.

P. Ayotte, S. Giroux, E. Dewailly, H. Avila, M. Farias et al., DDT spraying for malaria control and reproductive function in Mexican men, Epidemiology, vol.12, pp.366-367, 2001.

L. Hagmar, J. Björk, A. Sjödin, A. Bergman, and E. M. Erfurth, Plasma levels of persistent organohalogens and hormone levels in adult male humans, Arch Environ Health, vol.56, pp.138-143, 2001.

V. Persky, M. Turyk, H. A. Anderson, L. P. Hanrahan, and C. Falk, The effects of PCB exposure and fish consumption on endogenous hormones, Environ Health Perspect, pp.1275-1283, 2001.

S. A. Martin, S. D. Harlow, M. F. Sowers, M. P. Longnecker, and D. Garabrant, DDT metabolite and androgens in African-American farmers, Epidemiology, vol.13, pp.454-458, 2002.

J. Richthoff, L. Rylander, B. A. Jönsson, H. Akesson, and L. Hagmar, Serum levels of 2,29,4,49,5,59-hexachlorobiphenyl (CB-153) in relation to markers of reproductive function in young males from the general Swedish population, Environ Health Perspect, vol.111, pp.409-413, 2003.

M. A. Dalvie, J. E. Myers, L. Thompson, M. Dyer, S. Robins et al., The hormonal effects of long-term DDT exposure on malaria vector-control workers in Limpopo Province, South Africa. Environ Res, vol.96, pp.9-19, 2004.

A. Rignell-hydbom, L. Rylander, A. Giwercman, B. A. Jönsson, and P. Nilsson-ehle, Exposure to CB-153 and p,p9-DDE and male reproductive function, Hum Reprod, vol.19, pp.2066-2075, 2004.

R. Asawasinsopon, T. Prapamontol, O. Prakobvitayakit, Y. Vaneesorn, and A. Mangklabruks, Plasma levels of DDT and their association with reproductive hormones in adult men from northern Thailand, Sci Total Environ, vol.355, pp.98-105, 2006.

A. H. Giwercman, A. Rignell-hydbom, G. Toft, L. Rylander, and L. Hagmar, Reproductive hormone levels in men exposed to persistent organohalogen pollutants: a study of inuit and three European cohorts, Environ Health Perspect, vol.114, pp.1348-1353, 2006.

L. Rylander, E. Wallin, B. A. Jönssson, M. Stridsberg, and E. M. Erfurth, Associations between CB-153 and p,p9-DDE and hormone levels in serum in middle-aged and elderly men, Chemosphere, vol.65, pp.375-381, 2006.

M. E. Turyk, H. A. Anderson, S. Freels, R. Chatterton, and L. L. Needham, Associations of organochlorines with endogenous hormones in male Great Lakes fish consumers and nonconsumers, Environ Res, vol.102, pp.299-307, 2006.

A. Goncharov, R. Rej, S. Negoita, M. Schymura, and A. Santiago-rivera, Lower serum testosterone associated with elevated polychlorinated biphenyl concentrations in Native American men, Environ Health Perspect, vol.117, pp.1454-1460, 2009.

P. Langer, A. Kocan, B. Drobna, K. Susienkova, and Z. Radikova, Polychlorinated biphenyls and testosterone: age and congener related correlation approach in heavily exposed males, Endocr Regul, vol.44, pp.109-114, 2010.

T. B. Haugen, T. Tefre, G. Malm, B. A. Jönsson, and L. Rylander, Differences in serum levels of CB-153 and p,p9-DDE, and reproductive parameters between men living south and north in Norway, Reprod Toxicol, vol.32, pp.261-267, 2011.

J. Blanco-muñ-oz, M. Lacasañ-a, C. Aguilar-garduño, M. Rodríguez-barranco, and S. Bassol, Effect of exposure to p,p9-DDE on male hormone profile in Mexican flower growers, Occup Environ Med, vol.69, pp.5-11, 2012.

K. K. Ferguson, R. Hauser, L. Altshul, and J. D. Meeker, Serum concentrations of p, p9-DDE, HCB, PCBs and reproductive hormones among men of reproductive age, Reprod Toxicol, vol.34, pp.429-435, 2012.

P. Langer, A. Kocan, B. Drobna, K. Susienkova, and Z. Radikova, Blood testosterone in middle aged males heavily exposed to endocrine disruptors is decreasing more with HCB and p,p9-DDE related to BMI and lipids, but not with S15PCBs, Endocr Regul, vol.46, pp.51-59, 2012.

W. R. Kelce, C. R. Stone, S. C. Laws, L. E. Gray, and J. A. Kemppainen, Persistent DDT metabolite pp9-DDE is a potent androgen antagonist, Nature, vol.376, pp.581-585, 1995.

M. Plísková, J. Vondrácek, R. F. Canton, J. Nera, and A. Kocan, Impact of polychlorinated biphenyls contamination on estrogenic activity in human male serum, Environ Health Perspect, vol.113, pp.1277-1284, 2005.

G. Lemaire, W. Mnif, P. Mauvais, P. Balaguer, and R. Rahmani, Activation of alpha-and beta-estrogen receptors by persistent pesticides in reporter cell lines, Life Sci, vol.79, pp.1160-1169, 2006.

A. W. Hsing, F. Z. Stanczyk, A. Bélanger, P. Schroeder, and L. Chang, Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry, Cancer Epidemiol Biomarkers Prev, pp.1004-1008, 2007.

F. Z. Stanczyk and N. J. Clarke, Advantages and challenges of mass spectrometry assays for steroid hormones, J Steroid Biochem Mol Biol, vol.121, pp.491-495, 2010.

L. Multigner, J. R. Ndong, A. Giusti, M. Romana, and H. Delacroix-maillard, Chlordecone exposure and risk of prostate cancer, J Clin Oncol, vol.28, pp.3457-3462, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00518099

F. Giton, J. Fiet, J. N. Cornu, O. Cussenot, and A. Bélanger, Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry, Eur J Endocrinol, vol.165, pp.917-924, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00876034

F. Giton, P. Caron, . Bérubér, A. Bélanger, and O. Barbier, Plasma estrone sulfate assay in men: Comparison of radioimmunoassay, mass spectrometry coupled to gas chromatography (GC-MS), and liquid chromatography-tandem mass spectrometry (LC-MS/MS), Clin Chim Acta, vol.411, pp.1208-1213, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00515188

F. Giton, S. Urien, C. Born, J. Tichet, and J. Guéchot, Determination of bioavailable testosterone [non sex hormone binding globulin (SHBG)-bound testosterone] in a population of healthy French men: influence of androstenediol on testosterone binding to SHBG, Clin Chem, vol.53, pp.2160-2168, 2007.

C. Debier, P. P. Pomeroy, C. Dupont, C. Joiris, and V. Comblin, Quantitative dynamics of PCB transfer from mother to pup during lactation in UK grey seals Halichoerus grypus, Mar Ecol Prog Ser, vol.247, pp.237-248, 2003.

J. T. Bernert, W. E. Turner, D. G. Patterson, and L. L. Needham, Calculation of serum ''total lipid'' concentrations for the adjustment of persistent organohalogen toxicant measurements in human samples, Chemosphere, vol.68, pp.824-831, 2007.

Y. Jin, M. J. Hein, J. A. Deddens, and C. J. Hines, Analysis of lognormally distributed exposure data with repeated measures and values below the limit of detection using SAS, Ann Occup Hyg, vol.55, pp.97-112, 2011.

W. Sauerbrei and M. Schumacher, A bootstrap resampling procedure for model building: application to the Cox regression model, Stat Med, vol.11, pp.2093-2109, 1992.

R. A. Cohen, Classification by Using Stepwise Selection with Validation, Applications of GLMSELECT Procedure for Megamodel Section. SAS Global Forum, pp.19-22, 2009.

C. Dubuisson, F. Héraud, J. C. Leblanc, S. Gallotti, and C. Flamand, Impact of subsistence production on the management options to reduce the food exposure of the Martinican population to Chlordecone, Regul Toxicol Pharmacol, vol.49, pp.5-16, 2007.
URL : https://hal.archives-ouvertes.fr/anses-01875185

K. L. Becker, Principles and practice of endocrinology and metabolism, vol.957, 2001.

K. L. Schmidt, D. S. Pradhan, A. H. Shah, T. D. Charlier, and E. H. Chin, Neurosteroids, immunosteroids, and the Balkanization of endocrinology, Gen Comp Endocrinol, vol.157, pp.266-274, 2008.

W. Owens, L. E. Gray, E. Zeiger, M. Walker, and K. Yamasaki, The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies, Environ Health Perspect, vol.115, pp.671-678, 2007.

W. R. Kelce, C. R. Lambright, L. E. Gray, and K. P. Roberts, Vinclozolin and p,p9-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism, Toxicol Appl Pharmacol, vol.142, pp.192-200, 1997.

S. Lo, I. King, A. Alléra, and D. Klingmüller, Effects of various pesticides on human 5a-reductase activity in prostate and LNCaP cells, Toxicol in Vitro, vol.21, pp.502-508, 2007.

J. K. Amory and W. J. Bremner, Regulation of testicular function in men: implications for male hormonal contraceptive development, J Steroid Biochem Mol Biol, vol.85, pp.357-361, 2003.

P. S. Cooke, T. Sato, and D. L. Buchanan, Recent Advances in Environmental Toxicology and Health effects, pp.257-263, 2001.

E. C. Bonefeld-jørgensen, H. R. Andersen, T. H. Rasmussen, and A. M. Vinggaard, Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity, Toxicology, vol.158, pp.141-153, 2001.

S. M. Oh, B. T. Ryu, S. K. Lee, and K. H. Chung, Antiestrogenic potentials of ortho-PCB congeners by single or complex exposure, Arch Pharm Res, vol.30, pp.199-209, 2007.

M. H. Kester, S. Bulduk, D. Tibboel, W. Meinl, and H. Glatt, Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs, Endocrinology, vol.141, pp.1897-1900, 2000.

M. Machala, J. Neca, P. Drábek, R. Ulrich, and V. Sabatová, Effects of chronic exposure to PCBs on cytochrome P450 systems and steroidogenesis in liver and testis of bulls (Bos taurus), Comp Biochem Physiol A Mol Integr Physiol, vol.120, pp.65-70, 1998.

, Organochlorine Pollutants and Steroid Hormones

G. G. Kuiper, J. G. Lemmen, B. Carlsson, J. C. Corton, and S. H. Safe, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta, Endocrinology, vol.139, pp.4252-4263, 1998.

P. Thomas and J. Dong, Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption, J Steroid Biochem Mol Biol, vol.102, pp.175-179, 2006.

N. Benachour, S. Moslemi, H. Sipahutar, and G. E. Seralini, Cytotoxic effects and aromatase inhibition by xenobiotic endocrine disrupters alone and in combination, Toxicol Appl Pharmacol, vol.222, pp.129-140, 2007.

S. Ray, F. Xu, P. Li, N. S. Sanchez, and H. Wang, Increased level of cellular Bip critically determines estrogenic potency for a xenoestrogen kepone in the mouse uterus, Endocrinology, vol.148, pp.4774-4785, 2007.

J. Lee, R. C. Scheri, Y. Zhang, and L. R. Curtis, Chlordecone, a mixed pregnane X receptor (PXR) and estrogen receptor alpha (ERalpha) agonist, alters cholesterol homeostasis and lipoprotein metabolism in C57BL/6 mice, Toxicol Appl Pharmacol, vol.233, pp.193-202, 2008.

R. C. Cochran and M. A. Wiedow, Chlordecone lacks estrogenic properties in the male rat, Toxicol Appl Pharmacol, vol.76, pp.519-525, 1984.

E. S. Huang and F. R. Nelson, Anti-estrogenic action of chlordecone in rat pituitary gonadotrophs in vitro, Toxicol Appl Pharmacol, vol.82, pp.62-69, 1986.

L. Multigner, P. Kadhel, F. Huc-terki, J. P. Thome, and E. Janky, Exposure to Chlordecone and Male Fertility in Guadeloupe (French West Indies), Epidemiology, vol.17, p.372, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00697382

A. L. Eriksson, M. Lorentzon, L. Vandenput, F. Labrie, and M. Lindersson, Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men, J Clin Endocrinol Metab, vol.94, pp.1033-1041, 2009.

, Organochlorine Pollutants and Steroid Hormones

C. Acevedo, J. L. Opazo, C. Huidobro, J. Cabezas, and J. Iturrieta, Quiñones Sepúlveda L. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people, Prostate, vol.57, pp.111-117, 2003.

J. Acquavella, G. Olsen, P. Cole, B. Ireland, J. Kaneene et al., Cancer among farmers: a meta-analysis, Ann Epidemiol, vol.8, pp.64-74, 1998.

I. Agalliu, E. Karlins, E. M. Kwon, L. M. Iwasaki, A. Diamond et al., Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer, Br J Cancer, vol.97, pp.826-831, 2007.

I. Agalliu, R. Gern, S. Leanza, and R. D. Burk, Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations, Clin. Cancer Res, vol.15, pp.1112-1120, 2009.

J. A. Agúndez, C. Martínez, M. Olivera, L. Gallardo, J. M. Ladero et al., Expression in human prostate of drug-and carcinogenmetabolizing enzymes: association with prostate cancer risk, Br J Cancer, vol.78, pp.1361-1367, 1998.

A. Ahlbom, P. Lichtenstein, H. Malmström, M. Feychting, N. L. Pedersen et al., Cancer in Twins: Genetic and Nongenetic Familial Risk Factors, J Natl Cancer Inst, vol.89, pp.287-293, 1997.

J. Ahn, R. Moslehi, S. J. Weinstein, K. Snyder, J. Virtamo et al., Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study, Int J Cancer, vol.123, pp.1154-1159, 2008.

S. Akamats, R. Takata, C. A. Haiman, A. Takahashi, T. Inoue et al., Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese, Nat Genet, vol.44, pp.426-429, 2012.

O. Akinloye, J. Gromoll, and M. Simoni, Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians, Br J Biomed Sci, vol.68, pp.138-142, 2011.

M. C. Alavanja, D. P. Sandler, S. B. Mcmaster, S. H. Zahm, C. J. Mcdonnell et al., The Agricultural Health Study, Environ Health Perspect, vol.104, pp.362-369, 1996.

M. C. Alavanja, C. Samanic, M. Dosemeci, J. Lubin, R. Tarone et al., Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort, Am J Epidemiol, vol.157, pp.800-814, 2003.

D. D. Alexander, P. J. Mink, C. A. Cushing, and B. Sceurman, A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer, Nutr J, vol.9, p.50, 2010.

E. H. Allott, M. R. Abern, L. Gerber, C. J. Keto, W. J. Aronson et al., Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database, Prostate Cancer Prostatic Dis, vol.16, pp.391-397, 2013.

E. H. Allott, E. M. Masko, and S. J. Freedland, Obesity and prostate cancer: weighing the evidence, Eur Urol, vol.63, pp.800-809, 2013.

L. T. Amundadottir, P. Sulem, J. Gudmundsson, A. Helgason, A. Baker et al., A common variant associated with prostate cancer in European and African populations, Nat Genet, vol.38, pp.652-658, 2006.

P. Andersson, E. Varenhorst, and P. Söderkvist, Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk, Eur J Cancer, vol.42, pp.2833-2837, 2006.

S. O. Andersson, A. Wolk, R. Bergström, H. O. Adami, G. Engholm et al., Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers, J Natl Cancer Inst, vol.89, pp.385-389, 1997.

G. L. Andriole, E. D. Crawford, R. L. Grubb, S. S. Buys, D. Chia et al., Mortality Results from a Randomized Prostate-Cancer Screening Trial, N Engl J Med, vol.360, pp.1310-1319, 2009.

G. L. Andriole, E. D. Crawford, R. L. Grubb, S. S. Buys, D. Chia et al., Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up, J Natl Cancer Inst, vol.104, pp.125-132, 2012.

S. Angèle, A. Falconer, S. M. Edwards, T. Dörk, M. Bremer et al., ATM polymorphisms as risk factors for prostate cancer development, Br J Cancer, vol.91, pp.783-787, 2004.

C. Antognelli, L. Mearini, V. N. Talesa, A. Giannantoni, and E. Mearini, Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer, Prostate, vol.63, pp.240-251, 2005.

M. D. Anway, A. S. Cupp, M. Uzumcu, and M. K. Skinner, Epigenetic transgenerational actions of endocrine disruptors and male fertility, Science, vol.308, pp.1466-1469, 2005.

M. D. Anway and M. K. Skinner, Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease, Prostate, vol.68, pp.517-529, 2008.

L. Arab, J. Su, S. E. Steck, A. Ang, E. T. Fontham et al., Adherence to World Cancer Research Fund/American Institute for Cancer Research lifestyle recommendations reduces prostate cancer aggressiveness among African and Caucasian Americans, Nutr Cancer, vol.65, pp.633-643, 2013.

B. G. Armstrong and G. Kazantzis, Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: a case control study, Br J Ind Med, vol.42, pp.540-545, 1985.

K. J. Aronson, J. W. Wilson, M. Hamel, W. Diarsvitri, W. Fan et al., Plasma organochlorine levels and prostate cancer risk, J Expo Sci Environ Epidemiol, vol.20, pp.434-445, 2010.

S. O. Asbell, K. C. Rajmane, A. T. Montesano, K. L. Zeitzer, M. D. Asbell et al., Prostatespecific antigen and androgens in African-American and white normal subjects and prostate cancer patients, J Natl Med Assoc, vol.92, pp.445-449, 2000.

R. Asawasinsopon, T. Prapamontol, O. Prakobvitayakit, Y. Vaneesorn, A. Mangklabruks et al., Plasma levels of DDT and their association with reproductive hormones in adult men from northern Thailand, Sci. Total Environ, vol.355, pp.98-105, 2006.

K. Augustsson, D. S. Michaud, E. B. Rimm, M. F. Leitzmann, M. J. Stampfer et al., A Prospective Study of Intake of Fish and Marine Fatty Acids and Prostate Cancer, Cancer Epidemiol Biomarkers Prev, vol.12, pp.64-67, 2003.

P. Ayotte, S. Giroux, E. Dewailly, H. Avila, M. Farias et al., DDT spraying for malaria control and reproductive function in Mexican men, Epidemiology, vol.12, pp.47-58, 2001.

Y. Bai, Y. T. Gao, J. Deng, I. A. Sesterhenn, J. F. Fraumeni et al., Risk of prostate cancer and family history of cancer: a population-based study in China, Prostate Cancer Prostatic Dis, vol.8, pp.60-65, 2005.

P. R. Band, Z. Abanto, J. Bert, B. Lang, R. Fang et al., Prostate cancer risk and exposure to pesticides in British Columbia farmers, Prostate, vol.71, pp.168-183, 2011.

D. Bangsi, J. Zhou, Y. Sun, N. P. Patel, L. L. Darga et al., Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men, Urol Oncol, vol.24, pp.21-27, 2006.

L. E. Beane-freeman, M. R. Bonner, A. Blair, J. A. Hoppin, D. P. Sandler et al., Cancer incidence among male pesticide applicators in the Agricultural Health Study cohort exposed to diazinon, Am J Epidemiol, vol.162, pp.1070-1079, 2005.

L. E. Beane-freeman, J. A. Rusiecki, J. A. Hoppin, J. H. Lubin, S. Koutros et al., Atrazine and cancer incidence among pesticide applicators in the Agricultural Health Study, Environ Health Perspect, vol.119, pp.1253-1259, 1994.

J. L. Beebe-dimmer, E. A. Drake, R. L. Dunn, C. H. Bock, J. E. Montie et al., Association between family history of prostate and breast cancer among African-American men with prostate cancer, Urology, vol.68, pp.1072-1076, 2006.

J. L. Beebe-dimmer, R. L. Dunn, A. V. Sarma, J. E. Montie, and K. A. Cooney, Features of the metabolic syndrome and prostate cancer in African-American men, Cancer, vol.109, pp.875-881, 2007.

T. M. Beer, A. J. Evans, K. M. Hough, B. A. Lowe, J. E. Mcwilliams et al., Polymorphisms of GSTP1 and related genes and prostate cancer risk, Prostate Cancer Prostatic Dis, vol.5, pp.22-27, 2002.

S. Bellec and E. Godard, Contamination en produits phytosanitaires organochlorés en Martinique. Caractérisation de l'exposition des populations, Service Santé Environnement. DSDS Martinique, 2002.

L. Benbrahim-tallaa, M. M. Webber, and M. P. Waalkes, Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells, Environ Health Perspect, vol.115, pp.243-247, 2007.

Y. Ben-shlomo, S. Evans, F. Ibrahim, B. Patel, A. K. Chinegwundoh et al., PROCESS study group. The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study, Eur Urol, vol.53, pp.99-105, 2008.

H. A. Bern, P. Blair, S. Brasseur, T. Colborn, G. R. Cunha et al., Statement from the work session on chemically-induced alterations in sexual development : the wildlife/human connection. In: Chemically-induced alterations in sexual and functional development: the wildlife/human connection, Advances in modern environmental toxicology, vol.21, pp.1-8, 1992.

S. I. Berndt, J. L. Dodson, W. Y. Huang, and K. K. Nicodemus, A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk, J Urol, vol.175, pp.1613-1623, 2006.

J. T. Bernert, W. E. Turner, D. G. Patterson, and L. L. Needham, Calculation of serum « total lipid » concentrations for the adjustment of persistent organohalogen toxicant measurements in human samples, Chemosphere, vol.68, pp.824-831, 2007.

A. Berroukche, M. Bendahmane, and B. A. Kandouci, Association of diet with the risk of prostate cancer in Western Algeria, Oncologie, vol.14, pp.674-678, 2012.

P. Berthon, A. Valeri, A. Cohen-akenine, E. Drelon, T. Paiss et al., Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43, Am J Hum Genet, vol.62, pp.1416-1424, 1998.

J. Beuten, J. A. Gelfond, J. L. Franke, K. S. Weldon, A. C. Crandall et al., Single and Multigenic Analysis of the Association between Variants in 12 Steroid Hormone Metabolism Genes and Risk of Prostate Cancer, Pa tie -Tumeurs solides, vol.18, pp.1869-1880, 2009.

A. Blair, S. H. Zahm, N. E. Pearce, E. F. Heineman, and J. F. Fraumeni, Clues to cancer etiology from studies of farmers, Scand J Work Environ Health, vol.18, pp.209-215, 1992.

J. Blanco-muñoz, M. Lacasaña, C. Aguilar-garduño, M. Rodríguez-barranco, S. Bassol et al., DDE on male hormone profile in Mexican flower growers, Occup Environ Med, vol.69, pp.5-11, 2012.

D. Boers, M. P. Zeegers, G. M. Swaen, I. Kant, and P. A. Van-den-brandt, The influence of occupational exposure to pesticides, polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate cancer: a prospective cohort study, Occup Environ Med, vol.62, pp.531-537, 2005.

C. Bonilla, T. Mason, L. Long, C. Ahaghotu, W. Chen et al., E-cadherin polymorphisms and haplotypes influence risk for prostate cancer, Prostate, vol.66, pp.546-556, 2006.

M. R. Bonner, W. J. Lee, D. P. Sandler, J. A. Hoppin, M. Dosemeci et al., Occupational exposure to carbofuran and the incidence of cancer in the Agricultural Health Study, Environ Health Perspect, vol.113, pp.285-289, 2005.

M. R. Bonner, J. Coble, A. Blair, L. E. Beane-freeman, J. A. Hoppin et al., Malathion exposure and the incidence of cancer in the agricultural health study, Am J Epidemiol, vol.166, pp.1023-1034, 2007.

M. R. Bonner, B. A. Williams, J. A. Rusiecki, A. Blair, L. E. Beane-freeman et al., Occupational exposure to terbufos and the incidence of cancer in the Agricultural Health Study, Cancer Causes Control, vol.21, pp.871-877, 2010.

J. Bouyer, D. Hémon, S. Cordier, F. Derriennic, B. Stengel et al., Epidémiologie Principes et méthodes quantitatives, Les Editions Inserm, 1995.

G. S. Bova, A. W. Partin, S. D. Isaacs, B. S. Carter, T. L. Beaty et al., Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy, J Urol, vol.160, pp.660-663, 1998.

B. D. Bradbury, J. B. Wilk, and J. A. Kaye, Obesity and the risk of prostate cancer

, Cancer Causes Control, vol.16, pp.637-641, 2005.

A. Brandt, J. L. Bermejo, J. Sundquist, and K. Hemminki, Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members, Eur Urol, vol.58, pp.275-280, 2010.

A. Brandt, J. Sundquist, and K. Hemminki, Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer, Ann Oncol, vol.23, pp.251-256, 2012.

O. Bratt, U. Kristoffersson, R. Lundgren, and H. Olsson, Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study, Eur J Cancer, vol.35, pp.272-277, 1999.

O. Bratt, Hereditary prostate cancer: clinical aspects, J Urol, vol.168, pp.906-913, 2002.

M. Brinkman, R. C. Reulen, K. E. Buntinx, F. Zeegers, and M. P. , Are men with low selenium levels at increased risk of prostate cancer?, Eur J Cancer, vol.42, pp.2463-2471, 2006.

D. W. Bruner, D. Moore, A. Parlanti, J. Dorgan, and P. Engstrom, Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis, Int J Cancer, vol.107, pp.797-803, 2003.

W. H. Bulger, R. M. Muccitelli, and D. Kupfer, Studies on the estrogenic activity of chlordecone (Kepone) in the rat: effects on uterine estrogen receptor, Mol Pharmacol, vol.15, pp.515-524, 1979.

C. Burns, K. Bodner, G. Swaen, J. Collins, K. Beard et al., Cancer incidence of 2,4-D production workers, Int J Environ Res Public Health, vol.8, pp.3579-3590, 2011.

. Bvs-cire-antille-guyane, Epidémiologie des cancers aux Antilles-Guyane : focus sur quatre princiaples localisations. N°8-9, 2013.

G. Carruba, Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario, J Cell Biochem, vol.102, pp.899-911, 2007.

G. Cancel-tassin, A. Latil, A. Valéri, P. Mangin, G. Fournier et al., PCAP is the major known prostate cancer predisposing locus in families from south and west Europe, Eur J Hum Genet, vol.9, pp.135-142, 2001.

G. Cancel-tassin, A. Latil, F. Rousseau, P. Mangin, E. Bottius et al., Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies), Asian J Androl, vol.44, pp.1380-1385, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01118552

S. B. Cannon, J. M. Veazey, R. S. Jackson, V. W. Burse, C. Hayes et al., Epidemic Kepone poisoning in chemical workers, Am J Epidemiol, vol.107, pp.529-537, 1978.

B. S. Carter, T. H. Beaty, G. D. Steinberg, B. Childs, and P. C. Walsh, Mendelian inheritance of familial prostate cancer, Proc Natl Acad Sci, vol.89, pp.3367-3371, 1992.

C. Catsburg, A. D. Joshi, R. Corral, J. P. Lewinger, K. J. John et al., Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer, Carcinogenesis, vol.33, pp.1352-1359, 2012.

J. R. Cerhan, A. S. Parker, S. D. Putnam, B. C. Chiu, C. F. Lynch et al., Family history and prostate cancer risk in a population-based cohort of Iowa men, Cancer Epidemiol Biomarkers Prev, vol.8, pp.53-60, 1999.

H. J. Chalfin, S. B. Lee, B. C. Jeong, S. J. Freedland, H. Alai et al., Obesity and Long-Term Survival after Radical Prostatectomy, J Urol, issue.14, pp.3421-3422, 2014.

J. M. Chan, M. J. Stampfer, E. Giovannucci, P. H. Gann, J. Ma et al., Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study, Science, vol.279, pp.563-566, 1998.

B. Chang, S. L. Zheng, G. A. Hawkins, S. D. Isaacs, K. E. Wiley et al., Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk, Hum Genet, vol.110, pp.122-129, 2002.

B. Chang, S. L. Zheng, G. A. Hawkins, S. D. Isaacs, K. E. Wiley et al., Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility, Cancer Res, vol.62, pp.1784-1789, 2002.

M. Chang, Dual roles of estrogen metabolism in mammary carcinogenesis, BMB Rep, vol.44, pp.423-457, 2011.

L. E. Charles, D. Loomis, C. M. Shy, B. Newman, R. Millikan et al., Electromagnetic fields, polychlorinated biphenyls, and prostate cancer mortality in electric utility workers, Am J Epidemiol, vol.157, pp.683-691, 2003.

H. Checkoway, G. Diferdinando, B. S. Hulka, and D. D. Mickey, Medical, life-style, and occupational risk factors for prostate cancer, Prostate, vol.10, pp.79-88, 1987.

C. Chen, N. Lamharzi, N. S. Weiss, R. Etzioni, D. A. Dightman et al., Androgen receptor polymorphisms and the incidence of prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.11, pp.1033-1040, 2002.

C. J. Chen, T. L. Kuo, and M. M. Wu, Arsenic and cancers, Lancet, vol.1, pp.414-415, 1988.

C. Chen and C. J. Wang, Ecological Correlation between Arsenic Level in Well Water and Ageadjusted Mortality from Malignant Neoplasms, Cancer Res, vol.50, pp.5470-5474, 1990.

Y. C. Chen, J. H. Page, R. Chen, and E. Giovannucci, Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era, Prostate, vol.68, pp.1582-1591, 2008.

K. C. Chitra, C. Latchoumycandane, P. P. Mathur, A. P. Chokkalingam, M. Pollak et al., Insulin-like growth factors and prostate cancer: a population-based case-control study in China, Cancer Epidemiol Biomarkers Prev, vol.185, pp.421-427, 2001.

C. H. Christensen, E. A. Platz, G. Andreotti, A. Blair, J. A. Hoppin et al., Coumaphos exposure and incident cancer among male participants in the Agricultural Health Study (AHS), Environ Health Perspect, vol.118, pp.92-96, 2010.

M. S. Cicek, D. V. Conti, A. Curran, P. J. Neville, P. L. Paris et al., Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR

, Prostate, vol.59, pp.69-76, 2004.

F. Cillo, D. Eguileor, M. Gandolfi, F. Brevini, and T. A. , Aroclor-1254 affects mRNA polyadenylation, translational activation, cell morphology, and DNA integrity of rat primary prostate cells, Endocr Relat Cancer, vol.14, pp.257-266, 2007.

L. C. Clark, B. Dalkin, A. Krongrad, G. F. Combs, B. W. Turnbull et al., Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial, Br J Urol, vol.81, pp.730-734, 1998.

N. Clere, E. Lauret, Y. Malthiery, R. Andriantsitohaina, and S. Faure, Estrogen receptor alpha as a key target of organochlorines to promote angiogenesis, Angiogenesis, vol.15, pp.745-760, 2012.

P. Cocco, A. Loviselli, D. Fadda, A. Ibba, M. Melis et al., Serum sex hormones in men occupationally exposed to dichloro-diphenyl-trichloro ethane (DDT) as young adults, J Endocrinol, vol.182, pp.391-397, 2004.

P. Co-o, D. Fadda, M. Dillai-d,-d'at-i, and M. Melis, Cancer mortality among men occupationally exposed to dichlorodiphenyltrichloroethane, Cancer Res, vol.65, pp.9588-9594, 2005.

M. Cockburn, P. Mills, X. Zhang, J. Zadnick, D. Goldberg et al., Prostate cancer and ambient pesticide exposure in agriculturally intensive areas in California, Am J Epidemiol, vol.173, pp.1280-1288, 2011.

W. J. Cohn, J. J. Boylan, R. V. Blanke, M. W. Fariss, J. R. Howell et al., Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial, N Engl J Med, vol.298, pp.243-248, 1978.

P. P. Croghan-c-&-egeghy, Methods of Dealing With Values Below the Limit of Detection Using Sas. Presented at Southern SAS User Group, pp.22-24, 2003.

L. Cui, K. Dillehay, W. Chen, D. Shen, Z. Dong et al., Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis, Mol Biol Rep, vol.39, pp.7465-7471, 2012.

G. R. Cunha, Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate, Cancer, vol.74, pp.1030-1044, 1994.

O. Cussenot, A. R. Azzouzi, N. Nicolaiew, G. Fromont, P. Mangin et al., Cancel-Tassin G. Combination of Polymorphisms From Genes Related to Estrogen Metabolism and Risk of Prostate Cancers: The Hidden Face of Estrogens, J Clin Oncol, vol.25, pp.3596-3602, 2007.

L. Dal-maso, A. Zucchetto, L. Vecchia, C. Montella, M. Conti et al., Prostate cancer and body size at different ages: an Italian multicentre case-control study, Br J Cancer, vol.90, pp.2176-2180, 2004.

R. Dallaire, G. Muckle, F. Rouget, P. Kadhel, H. Bataille et al., Cognitive, visual, and motor development of 7-month-old Guadeloupean infants exposed to chlordecone, Environ Res, vol.118, pp.79-85, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00875939

M. A. Dalvie, J. E. Myers, L. Thompson, M. Dyer, S. Robins et al., The hormonal effects of long-term DDT exposure on malaria vectorcontrol workers in Limpopo Province, South Africa. Environ Res, vol.96, pp.9-19, 2004.

A. V. D'a-i-o, &. Whitti-gto, . Malko-i-z-sd, G. A. Dla-k-k,-d-ode-i-k, . Je et al., Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, vol.280, pp.969-974, 1998.

J. C. Davey, J. E. Bodwell, J. A. Gosse, and J. W. Hamilton, Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture, Toxicol Sci, vol.98, pp.75-86, 2007.

A. J. De-roos, B. A. Rusiecki, J. A. Hoppin, J. A. Svec, M. Dosemeci et al., Cancer incidence among glyphosate-exposed pesticide applicators in the Agricultural Health Study, Environ Health Perspect, vol.113, pp.49-54, 2005.

J. O. Delancey, M. C. Alavanja, J. Coble, A. Blair, J. A. Hoppin et al., Occupational exposure to metribuzin and the incidence of cancer in the Agricultural Health Study, Ann Epidemiol, vol.19, pp.388-395, 2009.

W. Demark-wahnefried, M. R. Conaway, C. N. Robertson, B. J. Mathias, E. E. Anderson et al., Anthropometric risk factors for prostate cancer, Nutr Cancer, vol.28, pp.302-307, 1997.

L. Dennis and D. V. Dawson, Meta-analysis of measures of sexual activity and prostate cancer, Epidemiology, vol.13, pp.72-79, 2002.

. Derbierc, P. P. Pomeroy, C. Dupont, C. Joiris, J. Comblin et al., Quantitative dynamics of PCB transfer from mother to pup during lactation in UK grey seals Halichoerus grypus, Mar Ecol Prog Ser, vol.247, pp.237-248, 2003.

J. Dillner, P. Knekt, J. Boman, M. Lehtinen, A. Geijersstam et al., Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer, Int J Cancer, vol.75, pp.564-567, 1998.

J. F. Dorgan, D. Albanes, J. Virtamo, O. P. Heinonen, D. W. Chandler et al., Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland, Cancer Epidemiol Biomarkers Prev, vol.7, pp.1069-1074, 1998.

M. Dosemeci, M. C. Alavanja, A. S. Rowland, D. Mage, S. H. Zahm et al., A quantitative approach for estimating exposure to pesticides in the Agricultural Health Study, Ann Occup Hyg, vol.46, pp.245-260, 2002.

D. Santos, A. Ribeiro, M. L. Mesquita, J. C. Carvalho-salles, A. B. Hackel et al., No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk, Prostate Cancer Prostatic Dis, vol.5, pp.28-31, 2002.

S. J. Ellem, J. F. Schmitt, J. S. Pedersen, M. Frydenberg, and G. P. Risbridger, Local aromatase expression in human prostate is altered in malignancy, J Clin Endocrinol Metab, vol.89, pp.2434-2441, 2004.

S. J. Ellem and G. P. Risbridger, The dual, opposing roles of estrogen in the prostate, Ann N Y Acad Sci, vol.1155, pp.174-186, 2009.

S. J. Ellem and G. P. Risbridger, Aromatase and regulating the estrogen: androgen ratio in the prostate gland, J Steroid Biochem Mol Biol, vol.118, pp.246-251, 2010.

H. Ellis-l-&-nyborg, Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health, Steroids, vol.57, pp.72-75, 1992.

E. Hormones, P. Group, A. W. Roddam, N. E. Allen, P. Appleby et al., Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies, J Natl Cancer Inst, vol.100, pp.170-183, 2008.

A. Engeland, S. Tretli, and T. Bjørge, Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men, Br J Cancer, vol.89, pp.1237-1242, 2003.

J. I. Epstein, W. C. Allsbrook, M. B. Amin, L. L. Egevad, and . Isup-grading-committee, The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, vol.29, pp.1228-1242, 2005.

V. Eroschenko and W. O. Wilson, Cellular changes in the gonads, livers,and adrenal glands of Japanese quail as affected by the insecticide kepone, Toxicol Appl Pharmacol, vol.3, pp.491-504, 1975.

V. P. Eroschenko and R. D. Palmiter, Estrogenicity of kepone in birds and mammals, Estrogens in the Environment, vol.427, pp.305-329, 1980.

V. P. Eroschenko, Estrogenic activity of the insecticide chlordecone in the reproductive tract of birds and mammals, J Toxicol Environ Health, vol.8, pp.731-742, 1981.

M. Etminan, B. Takkouche, and F. Caamaño-isorna, The Role of Tomato Products and Lycopene in the Prevention of Prostate Cancer: A Meta-Analysis of Observational Studies, Cancer Epidemiol Biomarkers Prev, vol.13, pp.340-345, 2004.

B. Ettinger, S. Sidney, S. R. Cummings, C. Libanati, D. D. Bikle et al., Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences, J Clin Endocrinol Metab, vol.82, p.434, 1997.

R. Evans, A. Kortenkamp, and O. Martin, State of the art assessment of endocrine disrupters

. F-fe-guso, . Kk, &. Hause, L. Altshul, and J. D. Meeke, Se u o e t atio s of p, p'-DDE, HCB, PCBs and reproductive hormones among men of reproductive age, Reprod Toxicol, vol.34, pp.429-435, 2012.

S. Figel and I. H. Gelman, Focal adhesion kinase controls prostate cancer progression via intrinsic kinase and scaffolding functions, Anticancer Agents Med Chem, vol.11, pp.607-623, 2011.

S. J. Freedland, W. J. Aronson, C. J. Kane, J. C. Presti, C. L. Amling et al., Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group, J Clin Oncol, vol.22, pp.446-453, 2004.

M. L. Freedman, C. A. Haiman, N. Patterson, G. J. Mcdonald, A. Tandon et al., Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men, Proc Natl Acad Sci U.S.A, vol.103, pp.278-283, 2004.

L. Fritschi, D. C. Glass, J. S. Tabrizi, J. E. Leavy, and G. L. Ambrosini, Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia, Occup Environ Med, vol.64, pp.60-65, 2007.

T. Fukatsu, Y. Hirokawa, T. Araki, T. Hioki, T. Murata et al., Genetic polymorphisms of hormonerelated genes and prostate cancer risk in the Japanese population, Anticancer Res, vol.24, pp.2431-2437, 2004.

H. Fukuda, N. Tsuchiya, S. Narita, T. Kumazawa, Y. Horikawa et al., Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer, Oncol Rep, vol.18, pp.1155-1163, 2007.

K. Fukutome, M. Watanabe, T. Shiraishi, M. Murata, H. Uemura et al., Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study, Cancer Epidemiol Biomarkers Prev, vol.136, pp.1041-1047, 1999.

P. Ghadirian, G. R. Howe, T. G. Hislop, and P. Maisonneuve, Family history of prostate cancer: A multicenter case-control study in Canada, Int J Cancer, vol.70, pp.679-681, 1997.

M. Gibbs, J. L. Stanford, R. A. Mcindoe, G. P. Jarvik, S. Kolb et al., Evidence for a Rare Prostate Cancer-Susceptibility Locus at Chromosome 1p36, Am J Hum Genet, vol.64, pp.776-787, 1999.

G. G. Giles, G. Severi, D. R. English, M. R. Mccredie, R. Macinnis et al., Early growth, adult body size and prostate cancer risk, Int J Cancer, vol.103, pp.241-245, 2003.

T. Gilligan, J. Manola, O. Sartor, S. P. Weinrich, J. W. Moul et al., Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population, Clin Prostate Cancer, vol.3, pp.98-103, 2004.

E. Giovannucci, M. J. Stampfer, K. Krithivas, M. Brown, D. Dahl et al., The CAG repeat within the androgen receptor gene and its relationship to prostate cancer, Proc Natl Acad Sci U.S.A, vol.94, pp.3320-3323, 1997.

E. Giovannucci and . Tomatoes, Tomato-Based Products, Lycopene, and Cancer: Review of the Epidemiologic Literature, J Natl Cancer Inst, vol.91, pp.317-331, 1999.

E. Giovannucci, E. B. Rimm, Y. Liu, M. Leitzmann, K. Wu et al., Body mass index and risk of prostate cancer in U.S. health professionals, J Natl Cancer Inst, vol.95, pp.1240-1244, 2003.

E. Giovannucci, Y. Liu, E. A. Platz, M. J. Stampfer, and W. C. Willett, Risk factors for prostate cancer incidence and progression in the health professionals follow-up study, Int J Cancer, vol.121, pp.1571-1578, 2007.

F. Giton, J. Fiet, J. N. Cornu, O. Cussenot, A. Bélanger et al., Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry, Eur J Endocrinol, vol.165, pp.917-924, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00876034

R. M. Giusti, J. L. Rutter, P. H. Duray, L. S. Freedman, M. Konichezky et al., A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology, Environ Health Perspect, vol.40, pp.1348-1353, 2003.

D. Gleason, The Veteran's Administration Cooperative Urologic Research Group: histologic grading and clinical staging of prostatic carcinoma, Tannenbaum, M. Urologic Pathology: The Prostate. Philadelphia: Lea and Febiger, pp.171-198, 1977.

F. E. Glover, D. S. Coffey, L. L. Douglas, H. Russell, M. Cadigan et al., Akwesasne Task Force on the Environment, Carpenter DO. Lower serum testosterone associated with elevated polychlorinated biphenyl concentrations in Native American men, Environ Health Perspect, vol.52, pp.1454-1460, 1998.

C. Gong, X. Hu, Y. Gao, Y. Cao, F. Gao et al., Genetic Polymorphisms of GSTM1, GSTT1, and GSTP1 with Prostate Cancer Risk: A Meta-Analysis of 57 Studies, Med Oncol, vol.28, p.2012, 2011.

E. L. Goode, J. L. Stanford, M. A. Peters, M. Janer, M. Gibbs et al., Clinical Characteristics of Prostate Cancer in an Analysis of Linkage to Four Putative Susceptibility Loci, Clin Cancer Res, vol.7, pp.2739-2749, 2001.

P. B. Gray, A. Kruger, H. W. Huisman, M. P. Wissing, and H. H. Vorster, Predictors of South African male testosterone levels: the THUSA study, Am J Hum Biol, vol.18, pp.123-132, 2006.

D. L. Greenburg, J. Rusiecki, S. Koutros, M. Dosemeci, R. Patel et al., Cancer incidence among pesticide applicators exposed to captan in the Agricultural Health Study, Cancer Causes Control, vol.19, pp.1401-1407, 2008.

H. Grönberg, L. Damber, and J. E. Damber, Studies of genetic factors in prostate cancer in a twin population, J Urol, vol.152, pp.1487-1489, 1994.

H. Grönberg, L. Damber, and J. E. Damber, Familial prostate cancer in sweden: A nationwide register cohort study, Cancer, vol.77, pp.138-143, 1996.

A. Gsur, M. Preyer, G. Haidinger, T. Zidek, S. Madersbacher et al., Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk, Carcinogenesis, vol.23, pp.1647-1651, 2002.

M. Gu, X. Dong, X. Zhang, and W. Niu, The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis, Mol Biol Rep, vol.39, pp.2615-2624, 2012.

L. Guldner, L. Multigner, F. Héraud, C. Monfort, J. P. Thomé et al., Pesticide exposure of pregnant women in Guadeloupe: ability of a food frequency questionnaire to estimate blood concentration of chlordecone, Environ Res, vol.110, pp.146-151, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00517109

L. A. Habel, S. K. Van-den-eeden, and G. D. Friedman, Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort, Prostate, vol.43, pp.136-143, 2000.

L. Hagmar, J. Björk, A. Sjödin, A. Bergman, and E. M. Erfurth, Plasma levels of persistent organohalogens and hormone levels in adult male humans, Arch Environ Health, vol.56, pp.138-143, 2001.

T. Hamasaki, H. Inatomi, T. Katoh, H. Aono, T. Ikuyama et al., Nacetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men, Int J Urol, vol.10, pp.167-173, 2003.

M. Han, A. W. Partin, M. Zahurak, S. Piantadosi, J. I. Epstein et al., Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer, J Urol, vol.169, pp.517-523, 2003.

I. H. Hanna, S. Dawling, N. Roodi, F. P. Guengerich, and F. F. Parl, Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity, Cancer Res, vol.60, pp.3440-3444, 2000.

L. Hardell, S. O. Andersson, M. Carlberg, L. Bohr, B. Van-bavel et al., Adipose tissue concentrations of persistent organic pollutants and the risk of prostate cancer, J Occup Environ Med, vol.48, pp.700-707, 2006.

L. W. Harries, M. J. Stubbins, D. Forman, G. C. Howard, and C. R. Wolf, Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer, Carcinogenesis, vol.18, pp.641-644, 1997.

T. B. Haugen, T. Tefre, G. Malm, B. A. Jönsson, L. Rylander et al., Differences in serum levels of CBa d p,p'-DDE, and reproductive parameters between men living south and north in Norway, Reprod Toxicol, vol.32, pp.261-267, 2011.

R. B. Hayes, J. M. Liff, L. M. Pottern, R. S. Greenberg, J. B. Schoenberg et al., Prostate cancer risk in U.S. blacks and whites with a family history of cancer, Int J Cancer, vol.60, pp.361-364, 1995.

V. M. Hayes, G. Severi, E. Padilla, M. H. Tilley, W. D. Southey et al., 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia, Int J Cancer, vol.120, pp.776-780, 2007.

M. Hedelin, E. T. Chang, F. Wiklund, R. Bellocco, A. Klint et al., Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism, Int J Cancer, vol.120, pp.398-405, 2007.

R. Heikkilä, K. Aho, M. Heliövaara, M. Hakama, J. Marniemi et al., Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study, Cancer, vol.86, pp.312-315, 1999.

O. P. Heinonen, D. Albanes, J. Virtamo, P. R. Taylor, J. K. Huttunen et al., Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial, J Natl Cancer Inst, vol.90, pp.440-446, 1998.

K. Hemminki-k-&-czene, Age specific and attributable risks of familial prostate carcinoma from the family-cancer database, Cancer, vol.95, pp.1346-1353, 2002.

B. E. Henderson, R. K. Ross, M. C. Pike, and T. Casagrande, Endogenous Hormones as a Major Factor in Human Cancer, Cancer Res, vol.42, pp.3232-3239, 1982.

A. J. Hennis, I. R. Hambleton, S. Y. Wu, D. H. Skeete, B. Nemesure et al., Prostate Cancer Incidence and Mortality in Barbados, West Indies. Prostate Cancer, 2011.

C. B. Herath, J. W. Watanabe, G. Arai, K. Suzuki, A. K. Taya et al., Adverse effects of environmental toxicants, octylphenol and bisphenol A, on male reproductive functions in pubertal rats, Endocrine, vol.25, pp.163-172, 2004.

A. L. Herbst and R. E. Scully, Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas), Cancer, vol.25, pp.745-757, 1970.

A. L. Herbst, H. Ulfelder, and D. C. Poskanzer, Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women, N Engl J Med, vol.284, pp.878-881, 1971.

L. Hilakivi-clarke, Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters, Breast Cancer Res, vol.16, p.208, 2014.

A. L. Hinwood, D. J. Jolley, and M. R. Sim, Cancer incidence and high environmental arsenic concentrations in rural populations: Results of an ecological study, Int J Environ Health Res, vol.9, pp.131-141, 1999.

J. B. Hjelmborg, T. Scheike, K. Holst, A. Skytthe, K. L. Penney et al., The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer, Cancer Epidemiol Biomarkers Prev, 2014.

S. M. Ho, W. Y. Tang, J. Belmonte-de-frausto, and G. S. Prins, Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4, Cancer Res, vol.66, pp.5624-5632, 2006.

C. N. Holick, J. L. Stanford, E. M. Kwon, E. A. Ostrander, S. Nejentsev et al., Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.16, 1990.

R. Hornung and L. D. Reed, Estimation of Average Concentration in the Presence of Nondetectable Values, Appl Occup Environ Hyg, vol.5, pp.46-51, 1990.

L. Hou, W. J. Lee, J. Rusiecki, J. A. Hoppin, A. Blair et al., Pendimethalin exposure and cancer incidence among pesticide applicators, Epidemiology, vol.17, pp.302-307, 2006.

A. W. Hsing, J. Deng, I. A. Sesterhenn, F. K. Mostofi, F. Z. Stanczyk et al., Body size and prostate cancer: a population-based case-control study in China, Cancer Epidemiol Biomarkers Prev, vol.9, pp.1335-1341, 2000.

A. W. Hsing, Y. T. Gao, G. Wu, X. Wang, J. Deng et al., Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China, Cancer Res, vol.60, pp.5111-5116, 2000.

L. Huang, Y. Pu, S. Alam, L. Birch, and G. S. Prins, Estrogenic regulation of signaling pathways and homeobox genes during rat prostate development, J Androl, vol.25, pp.330-337, 2004.

S. P. Huang, Y. H. Chou, W. S. Chang, M. T. Wu, C. C. Yu et al., Androgen receptor gene polymorphism and prostate cancer in Taiwan, J Formos Med Assoc, vol.102, pp.680-686, 2003.

Y. C. Huang, M. Chen, M. W. Lin, M. Y. Chung, Y. H. Chang et al., CYP19 TCT tri-nucleotide Del/Del genotype is a susceptibility marker for prostate cancer in a Taiwanese population, Urology, vol.69, pp.996-1000, 2007.

M. Huncharek, J. Muscat, and B. Kupelnick, Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies, Nutr Cancer, vol.60, pp.421-441, 2008.

Y. W. Hwang, S. Y. Kim, S. H. Jee, Y. N. Kim, and C. M. Nam, Soy Food Consumption and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies, I IARC. International Agency for Research on Cancer -Summaries & Evaluations. Chlrodecone, vol.61, pp.598-606, 1979.

R. A. Irvine, M. C. Yu, R. K. Ross, G. Coetzee, M. U. Jakobsen et al., The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer, Epidemiol Rev, vol.55, pp.77-87, 1937.

L. Järup, T. Bellander, C. Hogstedt, and G. Spång, Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel, Occup Environ Med, vol.55, pp.755-759, 1998.

L. Jian, L. P. Xie, A. H. Lee, and C. W. Binns, Protective effect of green tea against prostate cancer: A case-control study in southeast China, Int J Cancer, vol.108, pp.130-135, 2004.

Y. Jin, M. J. Hein, J. A. Deddens, and C. J. Hines, Analysis of Lognormally Distributed Exposure Data with Repeated Measures and Values below the Limit of Detection Using SAS, Ann Occup Hyg, vol.55, pp.97-112, 2011.

G. Johannesdottir, J. Gudmundsson, J. T. Bergthorsson, A. Arason, B. A. Agnarsson et al., High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients, Cancer Res, vol.56, pp.3663-3665, 1996.

E. M. John, M. C. Stern, R. Sinha, and J. Koo, Meat consumption, Cooking Practices, Meat Mutagens and Risk of Prostate Cancer, Nutr Cancer, vol.63, pp.525-537, 2011.

L. E. Johns and R. S. Houlston, A systematic review and meta-analysis of familial prostate cancer risk, BJU Int, vol.91, pp.789-794, 2003.

M. P. Jones, Indicator and Stratification Methods for Missing Explanatory Variables in Multiple Linear Regression, J Am Stat Assoc, vol.91, pp.222-230, 1996.

L. Justine, A. Gina, and F. Lin, Vietnam military service history and prostate cancer, BMC Public Health, vol.6, p.75, 2006.

P. Kadhel, E. Janky, and L. Multigner, Incidence and mortality of gynaecological cancers in Guadeloupe (French West Indies), Bull Cancer, vol.96, pp.157-164, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00504624

L. Kadhel-p-&-multigner, Age at breast cancer diagnosis in populations of african and European ancestry, Breast J, vol.20, pp.180-184, 2014.

L. A. Kalish, W. S. Mcdougal, and J. B. Mckinlay, Family history and the risk of prostate cancer, Urology, vol.56, pp.803-806, 2000.

I. Kallel, M. Rebai, and A. Rebai, Mutations and polymorphisms of estrogens receptors genes and diseases susceptibility, J Recept Signal Transduct Res, vol.32, pp.304-313, 2012.

D. Kang, S. K. Park, L. Beane-freeman, C. F. Lynch, C. E. Knott et al., Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study, Environ Res, vol.107, pp.271-276, 2008.

P. W. Kantoff, P. G. Febbo, E. Giovannucci, K. Krithivas, D. M. Dahl et al., A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis, Cancer Epidemiol Biomarkers Prev, vol.6, pp.189-192, 1997.

S. Karami, H. A. Young, and D. E. Henson, Earlier age at diagnosis: another dimension in cancer disparity?, Cancer Detect Prev, vol.31, pp.29-34, 2007.

A. Karatzas, E. Giannatou, V. Tzortzis, S. Gravas, E. Aravantinos et al., Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men, Cancer Epidemiol, vol.34, pp.345-349, 2010.

W. R. Kelce, C. R. Stone, S. C. Laws, L. E. Gray, J. A. Kemppainen et al., Persistent DDT eta olite p,p'-DDE is a potent androgen receptor antagonist, Nature, vol.375, pp.581-585, 1995.

J. E. Keller-byrne, S. A. Khuder, and E. A. Schaub, Meta-analyses of prostate cancer and farming, Am J Ind Med, vol.31, pp.580-586, 1997.

R. A. Keri, S. M. Ho, P. A. Hunt, K. E. Knudsen, A. M. Soto et al., An evaluation of evidence for the carcinogenic activity of bisphenol A, Reprod Toxicol, vol.24, pp.240-252, 2007.

A. Kermarrec, Niveau de la contamination des chaînes biologiques en Guadeloupe: Pesticides et métaux lourds, INRA, vol.651, pp.339-1979

M. H. Kester, S. Bulduk, H. Van-toor, D. Tibboel, W. Meinl et al., Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters, J Clin Endocrinol Metab, vol.87, pp.1142-1150, 2002.

A. S. Kibel, C. H. Jin, A. Klim, J. Luly, K. Roehl et al., Association between polymorphisms in cell cycle genes and advanced prostate carcinoma, Prostate, vol.68, pp.1179-1186, 2008.

M. Ki-i-ski, J. Va-g-o-sveld, and N. , A Epide iologi al 'eappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis, PLoS ONE, vol.6, 2011.

V. A. Kirsh, S. T. Mayne, U. Peters, N. Chatterjee, M. F. Leitzmann et al., A prospective study of lycopene and tomato product intake and risk of prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.15, pp.92-98, 2006.

R. A. Kittles, R. K. Panguluri, W. Chen, A. Massac, C. Ahaghotu et al., Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans, Cancer Epidemiol Biomarkers Prev, vol.10, pp.943-947, 2001.

T. Kjellström, L. Friberg, and B. Rahnster, Mortality and cancer morbidity among cadmium-exposed workers, Environ Health Perspect, vol.28, pp.199-204, 1979.

E. A. Klein, I. M. Thompson, C. M. Tangen, J. J. Crowley, M. S. Lucia et al., Vitamin e and the risk of prostate cancer: The selenium and vitamin e cancer prevention trial (select), JAMA, vol.306, pp.1549-1556, 2011.

L. N. Kolonel, Diet Fat, Meat, and Prostate Cancer, Epidemiol Rev, vol.23, pp.72-81, 2001.

S. V. Kotsis, S. L. Spencer, P. A. Peyser, J. E. Montie, and K. A. Cooney, Early onset prostate cancer: predictors of clinical grade, J Urol, vol.167, pp.1659-1663, 2002.

S. Koutros, R. Mahajan, T. Zheng, J. A. Hoppin, X. Ma et al., Dichlorvos exposure and human cancer risk: results from the Agricultural Health Study, Cancer Causes Control, vol.19, pp.59-65, 2008.

S. Koutros, C. F. Lynch, X. Ma, W. J. Lee, J. A. Hoppin et al., Heterocyclic aromatic amine pesticide use and human cancer risk: results from the U.S. Agricultural Health Study, Int J Cancer, vol.124, pp.1206-1212, 2009.

S. Koutros, M. C. Alavanja, J. H. Lubin, D. P. Sandler, J. A. Hoppin et al., An update of cancer incidence in the Agricultural Health Study, J Occup Environ Med, vol.52, pp.1098-1105, 2010.

S. Koutros, L. E. Freeman, J. H. Lubin, S. L. Heltshe, G. Andreotti et al., Risk of Total and Aggressive Prostate Cancer and Pesticide Use in the Agricultural Health Study, Am J Epidemiol, vol.177, pp.59-74, 2013.

V. Krishnaswamy, T. Kumarasamy, V. Venkatesan, S. Shroff, V. R. Jayanth et al., South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer, J Hum Genet, vol.51, pp.254-257, 2006.

A. R. Kristal, J. L. Stanford, J. H. Cohen, K. Wicklund, and R. E. Patterson, Vitamin and mineral supplement use is associated with reduced risk of prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.8, pp.887-892, 1999.

A. R. Kristal and J. W. Lampe, Brassica Vegetables and Prostate Cancer Risk: A Review of the Epidemiological Evidence, Nutr Cancer, vol.42, pp.1-9, 2002.

A. R. Kristal, A. K. Darke, J. S. Morris, C. M. Tangen, P. J. Goodman et al., Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk, J Natl Cancer Inst, vol.106, p.456, 2014.

G. G. Kuiper, J. G. Lemmen, B. Carlsson, J. C. Corton, S. H. Safe et al., Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta, Endocrinology, vol.139, pp.4252-4263, 1998.

L. Kupper and M. D. Hogan, Interaction in epidemiologic studies, Am J Epidemiol, vol.108, pp.447-453, 1978.

N. Kurahashi, M. Iwasaki, S. Sasazuki, T. Otani, M. Inoue et al., Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men, Br J Cancer, vol.94, pp.740-742, 2006.

N. Kurahashi, M. Iwasaki, S. Sasazuki, T. Otani, M. Inoue et al., Soy Product and Isoflavone Consumption in Relation to Prostate Cancer in Japanese Men, Cancer Epidemiol Biomarkers Prev, vol.16, pp.538-545, 2007.

N. Kurahashi, S. Sasazuki, M. Iwasaki, M. Inoue, S. Tsugane et al., Green tea consumption and prostate cancer risk in Japanese men: a prospective study, Am J Epidemiol, vol.167, pp.71-77, 2008.

D. D. Kwon, J. W. Lee, D. Y. Han, I. Y. Seo, S. C. Park et al., Relationship between the Glutathione-S-Transferase P1, M1, and T1 Genotypes and Prostate Cancer Risk in Korean Subjects, Korean J Urol, vol.52, pp.247-252, 2011.

E. M. Lange, A. V. Sarma, A. Ray, Y. Wang, L. A. Ho et al., The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-A e i a e : esults f o the Fli t Me 's Health Stud, J Hum Genet, vol.53, pp.220-226

P. Langer, A. Kocan, B. Drobna, K. Susienkova, Z. Radikova et al., Polychlorinated biphenyls and testosterone: age and congener related correlation approach in heavily exposed males, Endocr Regul, vol.44, pp.109-114, 2010.

P. Langer, A. Kocan, B. Drobna, K. Susienkova, Z. Radikova et al., Blood testosterone in middle aged males heavily exposed to endocrine disruptors is decreasing o e ith HCd a d p,p'-DDE related to BMI and lipids, but not with ?15PCBs, Endocr Regul, vol.46, pp.51-59, 2012.

A. G. Latil, R. Azzouzi, G. S. Cancel, E. C. Guillaume, B. Cochan-priollet et al., Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways, Cancer, vol.92, pp.1130-1137, 2001.

N. A. Lavender, M. L. Benford, T. T. Vancleave, G. N. Brock, R. A. Kittles et al., Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study, Cancer, vol.9, p.397, 2009.

J. Leavy, G. Ambrosini, and L. Fritschi, Vietnam military service history and prostate cancer, Public Health, vol.6, issue.75, 2006.

J. Lee, R. C. Scheri, Y. Zhang, and L. R. Curtis, Chlordecone a mixed pregnane X receptor (PXR) and estrogen receptor alpha (ERalpha) agonist, alters cholesterol homeostasis and lipoprotein metabolism in C57BL/6 mice, Toxicol Appl Pharmacol, vol.233, pp.193-202, 2008.

K. M. Lee, D. Kang, S. K. Park, S. I. Berndt, D. Reding et al., Nitric oxide synthase gene polymorphisms and prostate cancer risk, Carcinogenesis, vol.30, pp.621-625, 2009.

W. J. Lee, A. Blair, J. A. Hoppin, J. H. Lubin, J. A. Rusiecki et al., Cancer incidence among pesticide applicators exposed to chlorpyrifos in the Agricultural Health Study, J Natl Cancer Inst, vol.96, pp.1781-1789, 2004.

W. J. Lee, J. A. Hoppin, A. Blair, J. H. Lubin, M. Dosemeci et al., Cancer incidence among pesticide applicators exposed to alachlor in the Agricultural Health Study, Am J Epidemiol, vol.159, pp.373-380, 2004.

G. Lemaire, W. Mnif, P. Mauvais, P. Balaguer, and R. Rahmani, Activation of alpha-and betaestrogen receptors by persistent pesticides in reporter cell lines, Life Sci, vol.79, pp.1160-1169, 2006.

D. R. Lewis, J. W. Southwick, R. Ouellet-hellstrom, J. Rench, and R. L. Calderon, Drinking water arsenic in Utah: A cohort mortality study, Environ Health Perspect, vol.107, pp.359-365, 1999.

C. Li, H. Grönberg, H. Matsuyama, G. Weber, M. Nordenskjöld et al., Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibilitymodifying locus overlapping the androgen receptor gene, Int J Mol Med, vol.11, pp.529-533, 2003.

H. Li, M. J. Stampfer, J. B. Hollis, L. A. Mucci, J. M. Gaziano et al., A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer, PLoS Med, vol.4, p.103, 2007.

J. Li, R. J. Coates, M. Gwinn, and M. J. Khoury, Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review, Am J Epidemiol, vol.171, pp.1-13, 2010.

J. Li, E. Mercer, X. Gou, and Y. J. Lu, Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes, Am J Cancer Res, vol.3, pp.127-151, 2013.

L. Li, M. S. Cicek, G. Casey, and J. S. Witte, No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.13, pp.2280-2281, 2004.

Q. Li, M. Nishijo, H. Nakagawa, Y. Morikawa, M. Sakurai et al., Relationship between urinary cadmium and mortality in habitants of a cadmium-polluted area: a 22-year follow-up study in Japan, Chin Med J, vol.124, pp.3504-3509, 2011.

X. Li, Y. Huang, X. Fu, C. Chen, D. Zhang et al., Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer, Mutagenesis, vol.26, pp.371-383, 2011.

P. Lichtenstein, N. V. Holm, P. K. Verkasalo, A. Iliadou, J. Kaprio et al., Environmental and Heritable Factors in the Causation of Cancer -Analyses of Cohorts of Twins from Sweden, Denmark, and Finland, N Engl J Med, vol.343, pp.78-85, 2000.

M. M. Lima, M. N. Oliveira, F. Granja, A. C. Trindade, D. Castro-santos et al., Lack of association of GSTT1, GSTM1 GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients, Folia Biol. (Praha), vol.54, pp.102-108, 2008.

H. J. Lin, C. Y. Han, B. K. Lin, and S. Hardy, Slow acetylator mutations in the human polymorphic Nacetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology, Am J Hum Genet, vol.52, pp.827-834, 1993.

H. J. Lin, C. Y. Han, B. K. Lin, and S. Hardy, Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene, Pharmacogenetics, vol.4, pp.125-134, 1994.

Y. Lin, Z. Hu, X. Wang, Q. Mao, J. Qin et al., Tea consumption and prostate cancer: an updated meta-analysis, World J Surg Oncol, vol.12, p.38, 2014.

S. Lindström, S. L. Zheng, F. Wiklund, B. A. Jonsson, H. O. Adami et al., Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway, Prostate, vol.66, pp.1729-1743, 2006.

S. M. Lippman, P. J. Goodman, E. A. Klein, H. L. Parnes, I. M. Thompson et al., Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT), J Natl Cancer Inst, vol.97, pp.94-102, 2005.

S. M. Lippman, E. A. Klein, P. J. Goodman, M. S. Lucia, I. M. Thompson et al., Effect of selenium and vitamin e on risk of prostate cancer and other cancers: The selenium and vitamin e cancer prevention trial (select), JAMA, vol.301, pp.39-51, 2009.

H. J. Litman, S. Bhasin, C. L. Link, A. B. Araujo, and J. B. Mckinlay, Serum androgen levels in black, Hispanic, and white men, J Clin Endocrinol Metab, vol.91, pp.4326-4334, 2006.

R. Little and D. B. Rubin, Statistical Analysis with Missing Data, 1987.

S. Lo, I. King, A. Alléra, and D. Klingmüller, Effects of various pesticides on human 5alpha-reductase activity in prostate and LNCaP cells, Toxicol In Vitro, vol.21, pp.502-508, 2007.

J. M. Lobaccaro and A. Trousson, Environmental estrogen exposure during fetal life: a time bomb for prostate cancer, Endocrinology, vol.155, pp.656-658, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01939755

K. L. Lockett, M. C. Hall, J. Xu, S. L. Zheng, M. Berwick et al., The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function, Cancer Res, vol.64, pp.6344-6348, 2004.

T. Lotta, J. Vidgren, C. Tilgmann, I. Ulmanen, K. Melén et al., Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme, Biochemistry, vol.34, pp.4202-4210, 1995.

R. M. Lunn, D. A. Bell, J. L. Mohler, and J. A. Taylor, Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2), Carcinogenesis, vol.20, pp.1727-1731, 1999.

W. Luo, N. J. Birkett, A. M. Ugnat, and Y. Mao, Cancer incidence patterns among Chinese immigrant populations in Alberta, J Immigr Health, vol.6, pp.41-48, 2004.

C. J. Luscombe, M. E. French, S. Liu, M. F. Saxby, W. E. Farrell et al.,

S. M. Lynch, J. A. Rusiecki, A. Blair, M. Dosemeci, J. Lubin et al., Cancer incidence among pesticide applicators exposed to butylate in the Agricultural Health Study (AHS), Glutathione S-transferase GSTP1 genotypes are associated with response to androgen ablation therapy in advanced prostate cancer, vol.26, pp.860-868, 2002.

R. J. Macinnis and D. R. English, Body size and composition and prostate cancer risk: systematic review and meta-regression analysis, Cancer Causes Control, vol.17, pp.989-1003, 2006.

L. Magura, R. Blanchard, B. Hope, J. R. Beal, G. G. Schwartz et al., Hypercholesterolemia and prostate cancer: a hospital-based case-control study, Cancer Causes Control, vol.19, pp.1259-1266, 2008.

R. Mahajan, A. Blair, C. F. Lynch, P. Schroeder, J. A. Hoppin et al., Fonofos exposure and cancer incidence in the agricultural health study, Environ Health Perspect, vol.114, pp.1838-1842, 2006.

R. Mahajan, M. R. Bonner, J. A. Hoppin, and M. C. Alavanja, Phorate exposure and incidence of cancer in the agricultural health study, Environ Health Perspect, vol.114, pp.1205-1209, 2006.

R. Mahajan, A. Blair, J. Coble, C. F. Lynch, J. A. Hoppin et al., Carbaryl exposure and incident cancer in the Agricultural Health Study, Int J Cancer, vol.121, pp.1799-1805, 2007.

N. M. Makridakis, R. K. Ross, M. C. Pike, L. E. Crocitto, L. N. Kolonel et al., Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in, Lancet, vol.354, pp.975-978, 1999.

S. Mallick, P. Blanchet, and L. Multigner, Prostate Cancer Incidence in Guadeloupe, a French Caribbean Archipelago, Eur Urol, vol.47, pp.769-772, 2005.

S. Mallick, M. Romana, P. Blanchet, and L. Multigner, GSTM1 and GSTT1 Polymorphisms and the Risk of Prostate Cancer in a Caribbean Population of African Descent, Urology, vol.69, pp.1165-1169, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00688449

S. A. Martin, S. D. Harlow, M. F. Sowers, M. P. Longnecker, D. Garabrant et al., DDT metabolite and androgens in African-American farmers, Epidemiology, vol.13, pp.454-458, 2002.

G. Maskarinec and J. J. Noh, The effect of migration on cancer incidence among Japanese in Hawaii, Ethn Dis, vol.14, pp.431-439, 2004.

M. Mccracken, M. Olsen, M. S. Chen, A. Jemal, M. Thun et al., Cancer Incidence, Mortality, and Associated Risk Factors Among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese Ethnicities, CA Cancer J Clin, vol.57, pp.190-205, 2007.

J. E. Mcneal, Regional morphology and pathology of the prostate, Am J Clin Pathol, vol.49, pp.347-357, 1968.

P. J. Mcnicol and J. G. Dodd, Detection of papillomavirus DNA in human prostatic tissue by Southern blot analysis, Can J Microbiol, vol.36, pp.359-362, 1990.

R. M. Medeiros, A. Morais, A. Vasconcelos, S. Costa, D. Pinto et al., Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7, Clin Cancer Res, vol.8, pp.3433-3437, 2002.

C. Metcalfe, S. Evans, F. Ibrahim, B. Patel, A. K. Chinegwundoh et al., Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort study, Br J Cancer, vol.99, pp.1040-1045, 2008.

T. E. Meyer, A. L. Coker, M. Sanderson, and E. Symanski, A case-control study of farming and prostate cancer in African-American and Caucasian men, Occup Environ Med, vol.64, pp.155-160, 2007.

D. S. Michaud, K. Augustsson, E. B. Rimm, M. J. Stampfer, W. C. Willet et al., A prospective study on intake of animal products and risk of prostate cancer, Cancer Causes Control, vol.12, pp.557-567, 2001.

B. A. Miller, K. C. Chu, B. F. Hankey, and L. A. Ries, Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control, vol.19, pp.227-256, 2008.

P. Mills and R. Yang, Prostate cancer risk in California farm workers, J Occup Environ Med, vol.45, pp.249-258, 2003.

S. K. Mitra, D. A. Hanson, and D. D. Schlaepfer, Focal adhesion kinase: in command and control of cell motility, Nature Rev Mol Cell Biol, vol.6, pp.56-68, 2005.

R. D. Mittal, D. S. Srivastava, A. Mandhani, A. Kumar, and B. Mittal, Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: a study from North India, Indian J Cancer, vol.41, pp.115-119, 2004.

Z. Mo, Y. Gao, Y. Cao, F. Gao, and L. Jian, An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review, Prostate, vol.69, pp.662-688, 2009.

D. T. Molowa, S. A. Wrighton, R. V. Blanke, and P. S. Guzelian, Characterization of a unique aldo-keto reductase responsible for the reduction of chlordecone in the liver of the gerbil and man, J Toxicol Environ Health, vol.17, pp.375-384, 1986.

K. R. Monroe, M. C. Yu, L. N. Kolonel, G. A. Coetzee, L. R. Wilkens et al., Evidence of an X-linked or recessive genetic component to prostate cancer risk, Nat Med, vol.1, pp.827-829, 1995.

J. A. Montague, L. M. Butler, A. H. Wu, J. M. Genkinger, W. P. Koh et al., Green and black tea intake in relation to prostate cancer risk among Singapore Chinese, Cancer Causes Control, vol.23, pp.1635-1641, 2012.

T. O. Morgan, S. J. Jacobsen, W. F. Mccarthy, D. J. Jacobson, D. G. Mcleod et al., Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men, N Engl J Med, vol.335, pp.304-310, 1996.

G. Morganti, L. Gianferrari, A. Cresseri, G. Arrigoni, and G. Lovati, Clinico-statistical and genetic research on neoplasms of the prostate, Acta Genet Stat Med, vol.6, pp.304-305, 1956.

A. M. Mozzachio, J. A. Rusiecki, J. A. Hoppin, R. Mahajan, R. Patel et al., Chlorothalonil exposure and cancer incidence among pesticide applicator participants in the agricultural health study, Environ Res, vol.108, pp.400-403, 2008.

L. Multigner, J. R. Ndong, A. Giusti, M. Romana, H. Delacroix-maillard et al., Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol, Environ Health Perspect, vol.28, pp.70-76, 1997.

M. Nasterlack, G. Hoffmann, P. Messerer, M. G. Ott, D. Pallapies et al., Epidemiological and clinical investigations among employees in a former herbicide production process, Int Arch Occup Environ Health, vol.80, pp.234-238, 2007.

K. L. Nastiuk, M. Mansukhani, M. B. Terry, P. Kularatne, M. A. Rubin et al., Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men, Prostate, vol.40, pp.172-177, 1999.

E. Negri, C. Pelucchi, R. Talamini, M. Montella, S. Gallus et al., Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia, Int J Cancer, vol.114, pp.648-652, 2005.

B. Nemesure, S. Y. Wu, A. Hennis, and M. C. Leske, Family History of Prostate Cancer in a Black Population, J Immigr Minor Health, vol.15, pp.1107-1112, 2013.

C. Neslund-dudas, C. H. Bock, K. Monaghan, N. L. Nock, J. J. Yang et al., SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness, Prostate, vol.67, pp.1654-1663, 2007.

N. Nicolaiew, G. Cancel-tassin, A. R. Azzouzi, B. L. Grand, P. Mangin et al., Association between estrogen and androgen receptor genes and prostate cancer risk, Cancer Epidemiol Biomarkers Prev, vol.160, pp.621-625, 1996.

A. E. Norrish, L. R. Ferguson, M. G. Knize, J. S. Felton, S. J. Sharpe et al., Heterocyclic Amine Content of Cooked Meat and Risk of Prostate Cancer, J Natl Cancer Inst, vol.91, pp.2038-2044, 1999.

A. E. Norrish, C. M. Skeaff, G. L. Arribas, S. J. Sharpe, and R. T. Jackson, Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study, Br J Cancer, vol.81, pp.1238-1242, 1999.

C. Ntais, A. Polycarpou, J. P. Ioannidis, T. G. O-o'd-ie, Y. Guo et al., Watki s-Bruner D. Differences in ornithine decarboxylase and androgen receptor allele frequencies among ethnic groups, Cancer Epidemiol Biomarkers Prev, vol.12, pp.120-123, 2003.

C. Oddoux, J. P. Struewing, C. M. Clayton, S. Neuhausen, L. C. Brody et al., The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%, Nat Genet, vol.14, pp.188-190, 1996.

I. H. Onen, A. Ekmekci, M. Eroglu, E. Konac, S. Yesil et al., Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer, Exp Biol Med (Maywood), vol.233, pp.1608-1614, 2008.

E. S. Orwoll, C. M. Nielson, F. Labrie, E. Barrett-connor, J. A. Cauley et al., Osteoporotic Fractures in Men (MrOS) Research Group. Evidence for geographical and racial variation in serum sex steroid levels in older men, J Clin Endocrinol Metab, vol.95, pp.151-160, 2010.

R. Ottman, W. F. Page, M. M. Braun, A. W. Partin, N. Caporaso et al., Heredity and prostate cancer: a study of World War II veteran twins, Prev Med, vol.25, pp.240-245, 1996.

J. R. Palmer, L. A. Wise, E. E. Hatch, R. Troisi, L. Titus-ernstoff et al., Prenatal diethylstilbestrol exposure and risk of breast cancer, Cancer Epidemiol Biomarkers Prev, vol.15, pp.1509-1514, 2006.

R. D. Palmiter and E. R. Mulvihill, Estrogenic activity of the insecticide kepone on the chicken oviduct, Science, vol.201, pp.356-358, 1978.

V. R. Panz, B. I. Joffe, I. Spitz, T. Lindenberg, A. Farkas et al., Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men, Endocrine, vol.15, pp.213-216, 2001.

M. E. Parent, M. Désy, and J. Siemiatycki, Does exposure to agricultural chemicals increase the risk of prostate cancer among farmers?, Mcgill J Med, vol.12, pp.70-77, 2009.

S. K. Park, D. Kang, L. Beane-freeman, A. Blair, J. A. Hoppin et al., Cancer incidence among paraquat exposed applicators in the Agricultural Health Study: prospective cohort study, Int J Occup Environ Health, vol.15, pp.274-281, 2009.

Y. Park, M. F. Leitzmann, A. F. Subar, A. Hollenbeck, and A. Schatzkin, Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study, Arch Intern Med, vol.169, pp.391-401, 2009.

J. K. Parsons, H. B. Carter, E. A. Platz, E. J. Wright, P. Landis et al., Serum Testosterone and the Risk of Prostate Cancer: Potential Implications for Testosterone Therapy, Cancer Epidemiol Biomarkers Prev, vol.14, pp.2257-2260, 2005.

M. Pavuk, J. R. Cerhan, C. F. Lynch, A. Schecter, J. Petrik et al., Environmental exposure to PCBs and cancer incidence in eastern Slovakia, Chemosphere, vol.54, pp.1509-1520, 2004.

C. L. Pearce, N. M. Makridakis, R. K. Ross, M. C. Pike, L. N. Kolonel et al., Steroid 5-? Reductase Type II V89L Substitution Is Not Associated with Risk of Prostate Cancer in a Multiethnic Population Study, Cancer Epidemiol Biomarkers Prev, vol.11, pp.417-418, 2002.

C. L. Pearce, . Van-den, D. J. Berg, N. Makridakis, J. K. Reichardt et al., No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned, Hum Mol Genet, vol.17, pp.2456-2461, 2008.

V. Persky, M. Turyk, H. A. Anderson, L. P. Hanrahan, C. Falk et al., Great Lakes Consortium. The effects of PCB exposure and fish consumption on endogenous hormones, Environ Health Perspect, vol.109, pp.1275-1283, 2001.

U. Peters, A. J. Littman, A. R. Kristal, R. E. Patterson, J. D. Potter et al., Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort, Cancer Causes Control, vol.19, pp.75-87, 2008.

T. M. Pham, Y. Fujino, T. Kubo, R. Ide, N. Tokui et al., Fish intake and the risk of fatal prostate cancer: findings from a cohort study in Japan, Public Health Nutr, vol.12, pp.609-613, 2009.

E. A. Platz, E. B. Rimm, W. C. Willett, P. W. Kantoff, and E. Giovannucci, Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals, J Natl Cancer Inst, vol.92, 2000.

E. A. Platz, K. J. Helzlsouer, S. C. Hoffman, J. S. Morris, C. K. Baskett et al., Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk, Prostate, vol.52, pp.288-296, 2002.

E. A. Platz and E. Giovannucci, The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer, J Steroid Biochem Mol Biol, vol.92, pp.237-253, 2004.

M. Plísková, J. Vondrácek, R. F. Canton, J. Nera, A. Kocan et al., Impact of polychlorinated biphenyls contamination on estrogenic activity in human male serum, Environ Health Perspect, vol.113, pp.1277-1284, 2005.

S. J. Plummer, D. V. Conti, P. L. Paris, A. P. Curran, G. Casey et al., The E-Cadhe i ? C/A Polymorphism and Prostate Cancer Risk in White and Black American Men, Cancer Epidemiol Biomarkers Prev, vol.12, pp.793-796, 2003.

M. Porter, J. Stanford, M. M. Prince, A. M. Ruder, M. J. Hein et al., Mortality and Exposure Response among 14,458 Electrical Capacitor Manufacturing Workers Exposed to Polychlorinated Biphenyls (PCBs), Environ Health Perspect, vol.62, pp.1508-1514, 2005.

G. S. Prins and K. S. Korach, The role of estrogens and estrogen receptors in normal prostate growth and disease, Steroids, vol.73, pp.233-244, 2008.

G. S. Prins, S. H. Ye, L. Birch, S. Ho, and K. Kannan, Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal SpragueDawley rats, Reprod Toxicol, vol.31, pp.1-9, 2011.

S. Punnen, J. Hardin, I. Cheng, E. A. Klein, and J. S. Witte, Impact of Meat Consumption, Preparation, and Mutagens on Aggressive Prostate Cancer, PLoS ONE, vol.6, 2011.

M. P. Purdue, J. A. Hoppin, A. Blair, M. Dosemeci, A. Mc-;-q-qiu et al., Occupational exposure to organochlorine insecticides and cancer incidence in the Agricultural Health Study, Eur J Hum Genet J Urol, vol.120, pp.12-20, 2007.

T. R. Rebbeck, J. M. Jaffe, A. H. Walker, A. J. Wein, and S. B. Malkowicz, Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4, J Natl Cancer Inst, vol.90, pp.1225-1229, 1998.

T. R. Rebbeck, A. H. Walker, J. M. Jaffe, D. L. White, A. J. Wein et al., Glutathione Stransferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.8, pp.283-287, 1999.

H. Rennert, C. M. Zeigler-johnson, K. Addya, M. J. Finley, A. H. Walker et al., Association of Susceptibility Alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with Prostate Cancer Severity in European American and African American Men, Cancer Epidemiol Biomarkers Prev, vol.14, pp.949-957, 2005.

M. D. Reuber, . Carcinogenicity, and . Kepone, J Toxicol Environ Health, vol.4, pp.895-911, 1978.

J. Richthoff, L. Rylander, B. A. Jönsson, H. Akesson, L. Hagmar et al., Gi e a A. Se u levels of , ', ', '-hexachlorobiphenyl (CB-153) in relation to markers of reproductive function in young males from the general Swedish population, Environ Health Perspect, vol.111, pp.409-413, 2003.

A. Rignell-hydbom, L. Rylander, A. Giwercman, B. A. Jönsson, P. Nilsson-ehle et al., Exposure to CBa d p,p'-DDE and male reproductive function, Hum. Reprod, vol.19, 2004.

J. M. Ritchie, S. L. Vial, L. J. Fuortes, H. Guo, V. E. Reedy et al., Organochlorines and risk of prostate cancer, J Occup Environ Med, vol.45, pp.692-702, 2003.

J. M. Ritchie, S. L. Vial, L. J. Fuortes, L. W. Robertson, H. Guo et al., Comparison of proposed frameworks for grouping polychlorinated biphenyl congener data applied to a case-control pilot study of prostate cancer, Environ Res, vol.98, pp.104-113, 2005.

C. F. Robinson, M. Petersen, and S. Palu, Mortality patterns among electrical workers employed in the U.S. construction industry, 1982-1987, Am J Ind Med, vol.36, pp.630-637, 1999.

W. R. Robinson, J. Stevens, M. D. Gammon, and E. M. John, Obesity before age 30 years and risk of advanced prostate cancer, Am J Epidemiol, vol.161, pp.1107-1114, 2005.

I. S. Rodrigues, H. Kuasne, R. Losi-guembarovski, P. E. Fuganti, E. P. Gregório et al., Evaluation of the influence of polymorphic variants CYP1A1 2B, CYP1B1 2, CYP3A4 1B, GSTM1 0, and GSTT1 0 in prostate cancer, Urol Oncol, vol.29, pp.654-663, 2011.

C. Rodriguez, M. L. Mccullough, A. M. Mondul, E. J. Jacobs, D. Fakhrabadi-shokoohi et al., Calcium, Dairy Products, and Risk of Prostate Cancer in a Prospective Cohort of United States Men, Cancer Epidemiol Biomarkers Prev, vol.12, pp.597-603, 2003.

C. Rodriguez, S. J. Freedland, A. Deka, E. J. Jacobs, M. L. Mccullough et al., Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort, Cancer Epidemiol Biomarkers Prev, vol.16, pp.63-69, 2007.

E. G. Rogan and E. L. Cavalieri, Estrogen metabolites, conjugates, and DNA adducts: possible biomarkers for risk of breast, prostate, and other human cancers, AdvClin Chem, vol.38, pp.135-149, 2004.

S. Rohrmann, W. W. Roberts, P. C. Walsh, and E. A. Platz, Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer, Prostate, vol.55, pp.140-146, 2003.

S. Rohrmann, E. A. Platz, C. J. Kavanaugh, L. Thuita, S. C. Hoffman et al., Meat and dairy consumption and subsequent risk of prostate cancer in a US cohort study. Cancer Causes Control, vol.18, pp.41-50, 2007.

C. Rooney, V. Beral, N. Maconochie, P. Fraser, and G. Davies, Case-control study of prostatic cancer in employees of the United Kingdom Atomic Energy Authority, BMJ, vol.307, pp.1391-1397, 1993.

K. A. Rosenblatt, J. J. Carter, L. M. Iwasaki, D. A. Galloway, and J. L. Stanford, Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.12, pp.763-768, 2003.

W. Rosner, R. J. Auchus, R. Azziz, P. M. Sluss, and H. Raff, Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement, J Clin Endocrinol Metab, vol.92, pp.405-413, 2007.

R. K. Ross, H. Shimizu, A. Paganini-hill, G. Honda, and B. E. Henderson, Case-control studies of prostate cancer in blacks and whites in southern California, J Natl Cancer Inst, vol.78, pp.869-874, 1987.

K. J. Rothman, S. Greenland, and A. M. Walker, Concepts of interaction, Am J Epidemiol, vol.112, pp.467-470, 1980.

D. B. Rubin, A. M. Ruder, M. J. Hein, N. B. Hopf, and M. A. Waters, Mortality among 24,865 workers exposed to polychlorinated biphenyls (PCBs) in three electrical capacitor manufacturing plants: A tenyear update, Int J Hyg Environ Health, vol.217, pp.176-187, 1987.

J. A. Rusiecki, A. De-roos, W. J. Lee, M. Dosemeci, J. H. Lubin et al., Cancer incidence among pesticide applicators exposed to atrazine in the Agricultural Health Study, J Natl Cancer Inst, vol.96, pp.1375-1382, 2004.

J. A. Rusiecki, L. Hou, W. J. Lee, A. Blair, M. Dosemeci et al., Cancer incidence among pesticide applicators exposed to metolachlor in the Agricultural Health Study, Int J Cancer, vol.118, pp.3118-3123, 2006.

J. A. Rusiecki, R. Patel, S. Koutros, L. Beane-freeman, O. Landgren et al., Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health Study, Environ Health Perspect, vol.117, pp.581-586, 2009.

B. A. Rybicki, C. Neslund-dudas, N. L. Nock, L. R. Schultz, L. Eklund et al., Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism, Cancer Detect Prev, vol.30, p.422, 2006.

L. Rylander, E. Wallin, B. A. Jönssson, M. Stridsberg, E. M. Erfurth et al., Associations between CBa d p,p'-DDE and hormone levels in serum in middle-aged and elderly men

A. E. S-sahmoun, L. D. Case, S. A. Jackson, and G. G. Schwartz, Cadmium and prostate cancer: a critical epidemiologic analysis, Cancer Invest, vol.65, pp.256-263, 2005.

C. A. Salinas, M. A. Austin, E. O. Ostrander, and J. L. Stanford, Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk, Prostate, vol.65, pp.58-65, 2005.

C. A. Salinas, J. S. Koopmeiners, E. M. Kwon, L. Fitzgerald, D. W. Lin et al., Clinical utility of five genetic variants for predicting prostate cancer risk and mortality, Prostate, vol.69, pp.363-372, 2009.

C. Samanic, J. Rusiecki, M. Dosemeci, L. Hou, J. A. Hoppin et al., Cancer incidence among pesticide applicators exposed to dicamba in the agricultural health study, Environ Health Perspect, vol.114, pp.1521-1526, 2006.

A. Sander, J. Linseisen, and S. Rohrmann, Intake of heterocyclic aromatic amines and the risk of prostate cancer in the EPIC-Heidelberg cohort, Cancer Causes Control, vol.22, pp.109-114, 2011.

M. Sanderson, A. L. Coker, P. Logan, W. Zheng, and M. K. Fadden, Lifestyle and Prostate Cancer Among Older African-American and Caucasian Men in South Carolina, Cancer Causes Control, vol.15, pp.647-655, 2004.

A. V. Sarma, R. L. Dunn, L. A. Lange, A. Ray, Y. Wang et al., Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-A e i a e : the Fli t Me 's Health Stud, Prostate, vol.68, pp.296-305, 2008.

W. Sauerbrei and M. Schumacher, A bootstrap resampling procedure for model building: Application to the cox regression model, Statist Med, vol.11, 1992.

N. Sawada, M. Iwasaki, M. Inoue, H. Itoh, S. Sasazuki et al., Plasma organochlorines and subsequent risk of prostate cancer in Japanese men: a nested casecontrol study, Environ Health Perspect, vol.118, pp.659-665, 2010.

D. J. Schaid, S. K. Mcdonnell, M. L. Blute, and S. N. Thibodeau, Evidence for autosomal dominant inheritance of prostate cancer, Am J Hum Genet, vol.62, pp.1425-1438, 1998.

R. Schlaberg, D. J. Choe, K. R. Brown, H. M. Thaker, and I. R. Singh, XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors, Proc Natl Acad Sci U.S.A, vol.106, pp.16351-16356, 2009.

F. H. Schröder, J. Hugosson, M. J. Roobol, T. L. Tammela, S. Ciatto et al., Screening and Prostate-Cancer Mortality in a Randomized European Study, N Engl J Med, vol.360, pp.1320-1328, 2009.

F. H. Schröder, J. Hugosson, M. J. Roobol, T. L. Tammela, S. Ciatto et al., Prostate-Cancer Mortality at 11 Years of Follow-up, N Engl J Med, vol.366, pp.981-990, 2012.

A. G. Schuurman, R. A. Goldbohm, E. Dorant, and P. A. Van-den-brandt, Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study, Am J Epidemiol, vol.151, pp.541-549, 2000.

L. Settimi, A. Masina, A. Andrion, and O. Axelson, Prostate cancer and exposure to pesticides in agricultural settings, Int J Cancer, vol.104, pp.458-461, 2003.

T. Seisen, M. Rouprêt, A. Faix, and S. Droupy, La prostate : une glande au carrefour uro-génital

, Prog Urol, vol.22, pp.2-6, 2012.

G. Severi, H. A. Morris, R. J. Macinnis, D. R. English, W. Tilley et al., Circulating Steroid Hormones and the Risk of Prostate Cancer, Cancer Epidemiol Biomarkers Prev, vol.15, pp.86-91, 2006.

K. Shafique, P. Mcloone, K. Qureshi, H. Leung, C. Hart et al., Tea Consumption and the Risk of Overall and Grade Specific Prostate Cancer: A Large Prospective Cohort Study of Scottish Men, Nutr Cancer, vol.64, pp.790-797, 2012.

T. Shaneyfelt, R. Husein, G. Bubley, and C. S. Mantzoros, Hormonal Predictors of Prostate Cancer: A Meta-Analysis, J Clin Oncol, vol.18, pp.847-847, 2000.

L. Sharp, A. H. Cardy, S. C. Cotton, and J. Little, CYP17 Gene Polymorphisms: Prevalence and Associations with Hormone Levels and Related Factors. A HuGE Review, Am J Epidemiol, vol.160, p.740, 2004.

H. Shimizu, R. K. Ross, L. Bernstein, R. Yatani, B. E. Henderson et al., Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County, Br J Cancer, vol.63, pp.963-966, 1991.

R. Siegel, D. Naishadham, A. Jemal, Y. Silig, H. Pinarbasi et al., Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population, CA Cancer J Clin, vol.63, pp.41-45, 2006.

R. Sinha, Y. Park, B. I. Graubard, M. F. Leitzmann, A. Hollenbeck et al., Meat and Meat-related Compounds and Risk of Prostate Cancer in a Large Prospective Cohort Study in the United States, Am J Epidemiol, vol.170, pp.1165-1177, 2009.

J. Snegaroff, Organochlorines insecticidal residues in soils and rivers of banana-growing regions of Guadeloupe, Phytiar Phytopharm, vol.26, pp.251-67, 1977.

R. C. Sobti, K. Onsory, A. I. Al-badran, P. Kaur, M. Watanabe et al., CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population, DNA Cell Biol, vol.25, pp.1194-1198, 1997.

J. L. Stanford and E. A. Ostrander, Familial Prostate Cancer. Epidemiol Rev, vol.23, pp.19-23, 2001.

J. L. Stanford, E. A. Noonan, L. Iwasaki, S. Kolb, R. B. Chadwick et al., A polymorphism in the CYP17 gene and risk of prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.11, pp.243-247, 2002.

P. Stattin, A. Bylund, S. Rinaldi, C. Biessy, H. Déchaud et al., Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study, J Natl Cancer Inst, vol.92, 1910.

P. Stattin, S. Lumme, L. Tenkanen, H. Alfthan, E. Jellum et al., High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective study, Int J Cancer, vol.108, pp.418-424, 2004.

A. Steinbrecher, S. Rohrmann, M. Timofeeva, A. Risch, E. Jansen et al., Dietary Glucosinolate Intake, Polymorphisms in Selected Biotransformation Enzymes, and Risk of Prostate Cancer, Cancer Epidemiol Biomarkers Prev, vol.19, pp.135-143, 2010.

S. N. Stone, R. M. Hoffman, K. Tollestrup, C. A. Stidley, J. L. Witter et al., Family history, Hispanic ethnicity, and prostate cancer risk, Ethn Dis, vol.13, pp.233-239, 2003.

S. S. Strom, Y. Yamamura, C. M. Duphorne, M. R. Spitz, R. J. Babaian et al., Phytoestrogen intake and prostate cancer: A case-control study using a new database, Nutr Cancer, vol.33, pp.20-25, 1999.

S. S. Strom, Y. Yamamura, F. N. Flores-sandoval, C. A. Pettaway, and D. S. Lopez, Prostate cancer in Mexican-Americans: Identification of risk factors, Prostate, vol.68, pp.563-570, 2008.

J. P. Struewing, P. Hartge, S. Wacholder, S. M. Baker, M. Berlin et al., The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews, N Engl J Med, vol.336, pp.1401-1408, 1997.

Y. Sugiyama, N. Masumori, F. Fukuta, A. Yoneta, T. Hida et al., Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk, Asian Pac J Cancer Prev, vol.14, pp.1-4, 2013.

J. Sun, B. L. Chang, S. D. Isaacs, K. E. Wiley, F. Wiklund et al., Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations, Prostate, vol.68, pp.1257-1262, 2008.

K. Suzuki, H. Nakazato, H. Matsui, H. Koike, H. Okugi et al., Association of the genetic polymorphism of the CYP19 intron 4 [TTTA]n repeat with familial prostate cancer risk in a Japanese population, Anticancer Res, vol.23, pp.4941-4946, 2003.

M. Suzuki, T. Kurosaki, T. Arai, M. Sawabe, T. Hosoi et al., The Val158Metpolymorphism of the catechol-O-methyltransferase gene is not associated with the risk of sporadic or latent prostate cancer in Japanese men, Int J Urol, vol.14, pp.800-804, 2007.

T. Suzuki, K. Matsuo, K. Wakai, A. Hiraki, K. Hirose et al., Effect of familial history and smoking on common cancer risks in Japan, Cancer, vol.109, pp.2116-2123, 2007.

A. Szendroi, G. Speer, A. Tabak, J. P. Kosa, P. Nyirady et al., The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer, Can J Urol, vol.18, pp.5710-5716, 2011.

A. Sz-a-ska-chabowska, J. Antonowicz-juchniewicz, and R. Andrzejak, Plasma concentration of selected neoplastic markers in persons occupationally exposed to arsenic and heavy metals

, Med Pr, vol.55, pp.313-320, 2004.

E. Taioli, R. E. Flores-obando, I. Agalliu, P. Blanchet, C. H. Bunker et al., Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent, Carcinogenesis, vol.32, pp.1361-1365, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00682901

R. Talamini, L. Vecchia, C. Decarli, A. Negri, E. Franceschi et al., Nutrition, social factors and prostatic cancer in a Northern Italian population, Br J Cancer, vol.53, pp.817-821, 1986.

L. Tang, S. Yao, C. Till, P. J. Goodman, C. M. Tangen et al., Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial, Carcinogenesis, vol.32, pp.1500-1506, 2011.

Y. M. Tang, B. L. Green, G. F. Chen, P. A. Thompson, N. P. Lang et al., Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese

, and distribution in prostate cancer cases and controls, Pharmacogenetics, vol.10, pp.761-766, 2000.

M. L. Taylor, A. G. Mainous, and B. J. Wells, Prostate cancer and sexually transmitted diseases: a metaanalysis, Fam Med, vol.37, pp.506-512, 2005.

A. L. Teixeira, R. Ribeiro, D. Cardoso, D. Pinto, F. Lobo et al., Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients, Clin Cancer Res, vol.14, pp.3367-3371, 2008.

P. Terry, P. Lichtenstein, M. Feychting, A. Ahlbom, and A. Wolk, Fatty fish consumption and risk of prostate cancer, Lancet, vol.357, pp.1764-1766, 2001.

P. D. Terry, T. E. Rohan, and A. Wolk, Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence, Am J Clin Nutr, vol.77, pp.532-543, 2003.

H. Thakur, L. Gupta, R. C. Sobti, A. K. Janmeja, A. Seth et al., Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population, Mol Biol Rep, vol.38, pp.1733-1739, 2011.

T. C. Thompson, G. R. Cunha, J. M. Shannon, and L. W. Chung, Androgen-induced biochemical responses in epithelium lacking androgen receptors: characterization of androgen receptors in the mesenchymal derivative of urogenital sinus, J Steroid Biochem, vol.25, pp.627-634, 1986.

H. Thorne, A. J. Willems, E. Niedermayr, I. M. Hoh, J. Li et al., Consortium for Research in Familial Breast Cancer Consortium, Bolton D. Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families, Cancer Prev Res (Phila), vol.4, pp.1002-1010, 2011.

R. C. Travis, T. J. Key, N. E. Allen, P. N. Appleby, A. W. Roddam et al., Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition, Int J Cancer, vol.121, pp.1331-1338, 2007.

L. Tryggvadóttir, L. Vidarsdóttir, T. Thorgeirsson, J. G. Jonasson, E. J. Olafsdóttir et al., Prostate cancer progression and survival in BRCA2 mutation carriers, J Natl Cancer Inst, vol.99, pp.929-935, 2007.

S. M. Tsai, T. N. Wang, and Y. C. Ko, Mortality for certain diseases in areas with high levels of arsenic in drinking water, Arch Environ Health, vol.54, pp.186-193, 1999.

N. Tsuchiya, L. Wang, H. Suzuki, T. Segawa, H. Fukuda et al., Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer, J Clin Oncol, vol.24, 1982.

F. Turati, V. Edefonti, C. Bosetti, M. Ferraroni, M. Malvezzi et al., Family history of cancer and the risk of cancer: a network of case-control studies, Ann Oncol, vol.24, pp.2651-2656, 2013.

M. E. Turyk, H. A. Anderson, S. Freels, R. Chatterton, L. L. Needham et al., Sethyl-N,N-dipropylthiocarbamate exposure and cancer incidence among male pesticide applicators in the Agricultural Health Study: a prospective cohort, Environ Health Perspect, vol.102, pp.1541-1546, 2001.

S. Van-buuren, H. C. Boshuizen, D. Knook, J. W. Van-der-gulden, J. J. Kolk et al., Multiple imputation of missing blood pressure covariates in survival analysis, Prostate, vol.18, pp.250-257, 1995.

M. D. Van-die, K. M. Bone, S. G. Williams, and M. V. Pirotta, Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials, BJU Int, vol.113, pp.119-130, 2014.

G. V. Van-maele-fabry and J. L. Willems, Van Maele-Fabry GV & Willems JL. Prostate cancer among pesticide applicators: a metaanalysis, Int Arch Occup Environ Health, vol.60, pp.559-570, 2003.

G. V. Van-maele-fabry, V. Libotte, J. Willems, and D. Lison, Review and meta-analysis of risk estimates for prostate cancer in pesticide manufacturing workers, Cancer Causes Control, vol.17, pp.353-373, 2006.

A. Vazina, J. Baniel, Y. Yaacobi, A. Shtriker, D. Engelstein et al., The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel, Br J Cancer, vol.83, pp.463-466, 2000.

M. B. Veierød, P. Laake, and D. S. Thelle, Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men, Int J Cancer, vol.73, pp.634-638, 1997.

V. Venkateswaran, N. E. Fleshner, L. M. Sugar, and L. H. Klotz, Antioxidants block prostate cancer in lady transgenic mice, Cancer Res, vol.64, pp.5891-5896, 2004.

B. A. Verhage, A. B. Baffoe-bonnie, L. Baglietto, D. S. Smith, J. E. Bailey-wilson et al., Autosomal dominant inheritance of prostate cancer: a confirmatory study, Urology, vol.57, pp.97-101, 2001.

B. A. Verhage, K. Van-houwelingen, T. E. Ruijter, L. A. Kiemeney, and J. A. Schalken, Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer, Int J Cancer, vol.100, pp.683-685, 2002.

J. J. Versluys, Cancer and occupation in the Netherlands, Br J Cancer, vol.3, pp.161-185, 1949.

K. Vijayalakshmi, K. Thangaraj, S. Rajender, V. Vettriselvi, P. Venkatesan et al., GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men, J Hum Genet, vol.51, pp.998-1005, 2006.

H. D. Vlaji-a, J. M. Ma-i-kovi, M. D. Ili, and E. Ko,

, Eur J Cancer, vol.33, pp.101-107, 1997.

P. M. Vonier, D. A. Crain, J. A. Mclachlan, L. J. Guillette, A. Sf-;-w-wadelius et al., Interaction of environmental chemicals with the estrogen and progesterone receptors from the oviduct of the American alligator, Environ Health Perspect, vol.104, pp.333-340, 1996.

S. D. Walter and T. R. Holford, Additive, multiplicative, and other models for disease risks, Am J Epidemiol, vol.108, pp.341-346, 1978.

C. Y. Wang, M. Debiec-rychter, H. A. Schut, P. Morse, R. F. Jones et al., NAcetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium, Carcinogenesis, vol.20, pp.1591-1595, 1999.

F. Wang, Y. F. Zou, X. L. Feng, H. Su, and F. Huang, CYP17 gene polymorphisms and prostate cancer risk: A meta-analysis based on 38 independent studies, Prostate, vol.71, pp.1167-1177, 2011.

B. Wei, Z. Xu, Y. Zhou, J. Ruan, H. Cheng et al., Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies, PLoS ONE, vol.7, p.2012

D. W. West, M. L. Slattery, L. M. Robison, T. K. French, and A. W. Mahoney, Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors, Cancer Causes Control, vol.2, pp.85-94, 1991.

Y. B. Wetherill, J. K. Hess-wilson, C. E. Comstock, S. A. Shah, C. R. Buncher et al., Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer, Mol Cancer Ther, vol.5, pp.3181-3190, 2006.

A. S. Whittemore, A. H. Wu, L. N. Kolonel, E. M. John, R. P. Gallagher et al., Family History and Prostate Cancer Risk in Black, White, and Asian Men in the United States and Canada, Am J Epidemiol, vol.141, pp.732-740, 1995.

E. P. Wilkens, D. Freije, J. Xu, D. R. Nusskern, H. Suzuki et al., No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer, Prostate, vol.39, pp.280-284, 1999.

S. J. Winters, A. Brufsky, J. Weissfeld, D. L. Trump, M. A. Dyky et al., Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men, Metabolism, vol.50, pp.1242-1247, 2001.

M. E. Wright, S. C. Chang, A. Schatzkin, D. Albanes, V. Kipnis et al., Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality, Cancer, vol.109, pp.675-684, 2007.

A. H. Wu, A. S. Whittemore, L. N. Kolonel, E. M. John, R. P. Gallagher et al., Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada, Cancer Epidemiol Biomarkers Prev, vol.4, pp.735-741, 1995.

A. H. Wu, C. C. Tseng, . Van-den, D. Berg, Y. Mc-;-wu et al., Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases, Am J Epidemiol, vol.63, pp.1123-1132, 1989.

L. Xiao, M. Tong, Y. Jin, W. Huang, and Z. Li, The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis, Mol Biol Rep, vol.40, pp.1835-1841, 2013.

J. Xu, D. Meyers, D. Freije, S. Isaacs, K. Wiley et al., Evidence for a prostate cancer susceptibility locus on the X chromosome, Nat Genet, vol.20, pp.175-179, 1998.

J. Xu, Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics, Am J Hum Genet, vol.66, pp.945-957, 2000.

X. Xu, A. B. Dailey, E. O. Talbott, V. A. Ilacqua, G. Kearney et al., Associations of serum concentrations of organochlorine pesticides with breast cancer and prostate cancer in U.S. adults. Environ Health Perspect, vol.118, pp.60-66, 2010.

W. Xue, R. A. Irvine, M. C. Yu, R. K. Ross, G. A. Coetzee et al., Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci, Cancer Res, vol.60, pp.839-841, 2000.

L. Yan and E. L. Spitznagel, Meta-analysis of soy food and risk of prostate cancer in men, Int J Cancer, vol.117, pp.667-669, 2005.

Q. Yang, J. Du, and X. Yao, Significant association of Glutathione S-transferase T1 null genotype with prostate cancer risk: a meta-analysis of 26,393 subjects. PLoS ONE. 8, e53700, 2013.

S. Yao, C. Till, A. R. Kristal, P. J. Goodman, A. W. Hsing et al., Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study, Cancer Causes Control, vol.22, pp.1121-1131, 2011.

C. Y. Yonemura, G. R. Cunha, Y. Sugimura, and S. L. Mee, Temporal and spatial factors in diethylstilbestrol-induced squamous metaplasia in the developing human prostate. II. Persistent changes after removal of diethylstilbestrol, Acta Anat (Basel), vol.153, pp.1-11, 1995.

H. Yu, R. E. Harris, Y. T. Gao, R. Gao, and E. Wynder, Comparative epidemiology of cancers of the colon, rectum prostate and breast in Shanghai, China versus the United States, Int J Epidemiol, vol.20, p.327, 1991.

W. J. Yu, B. J. Lee, S. Y. Nam, B. Ahn, J. T. Hong et al., Reproductive disorders in pubertal and adult phase of the male rats exposed to vinclozolin during puberty, J Vet Med Sci, vol.66, pp.847-853, 2004.

Z. Yu, Z. Li, B. Cai, Z. Wang, W. Gan et al., How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?, Cancer Epidemiol Biomarkers Prev, vol.34, pp.1765-1771, 2004.

C. M. Zeigler-johnson, E. Spangler, M. Jalloh, S. M. Gueye, H. Rennert et al., Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes, Can J Urol, vol.15, pp.3872-3882, 2008.

H. Zhang, Z. Zhang, J. Wu, Y. Xu, R. Cheng et al., Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility, Urol. Int, vol.91, pp.213-219, 2013.

J. Zheng, B. Yang, T. Huang, Y. Yu, J. Yang et al., Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies, Nutr Cancer, vol.63, pp.663-672, 2011.

W. Zheng and S. A. Lee, Well-done Meat Intake, Heterocyclic Amine Exposure and Cancer Risk, Nutr Cancer, vol.61, pp.437-446, 2009.

Y. S. Zhu, Molecular Basis of Steroid Action in the Prostate, Cellscience, vol.1, pp.27-55, 2005.

L. Zou, X. Xu, T. Liu, H. Wang, W. Fan et al., No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis, Genet Test Mol Biomarkers, vol.17, pp.78-84, 2013.

K. Zu and C. Ip, Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells, Cancer Res, vol.63, pp.6988-6995, 2003.

K. Zu, L. Mucci, B. A. Rosner, S. K. Clinton, M. Loda et al., Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era, J Natl Cancer Inst, vol.106, 2014.